rfhg_226203.1

Basic information about the TSS

---

TSS ID: rfhg_226203.1 Species: human Chr: chr21		Start: 39348661 End: 39348671 Strand: -
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	pELS,CTCF-bound (EH38D3342268,EH38E2142511)
Category:	pELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000482192.5:38 GeneID: 3150 HGNC/MGI_ID: HGNC:4984 UniProt_ID: Nearer transcript ids and distances: ENST00000471260.1:41 ENST00000485550.5:64 ENST00000489072.5:-191 BT007337:-246 KJ891359:-246 AB590110:-246 DQ891741:-251 DQ894919:-251 ENST00000288344.14:-320 ENST00000490032.5:322 ENST00000652622.1:-340 ENST00000479586.5:-344 BC071643:-348 ENST00000482733.1:-349 BC023984:-359 BC072672:-359 BC070154:-368 ENST00000419378.5:-369 BC000075:-370 ENST00000380748.5:-382 ENST00000443046.5:-383 ENST00000464078.5:-383 ENST00000463631.1:-383 AB209245:-383 BC106080:-383 BC070153:-388 J02621:-390 AK315410:-392 ENST00000491183.5:-396 ENST00000380749.10:-417 ENST00000436324.5:-417 NM_004965.7:-417 ENST00000486741.5:-428 BC107741:-452 ENST00000431390.5:-469 view more...

Gene_name: high mobility group nucleosome binding domain 1 Gene_symbol: HMGN1 Gene_synonyms: FLJ27265 FLJ31471 MGC104230 MGC117425 Gene_source: HGNC:4984

TATA-Box annotation

---

Distance to TSS:	422
Nearest PromoterID:	NM_004965
Entrez ID:	3150
Nearest Unigene:	Hs.356285
Nearest Refseq:	NM_004965
Nearest Ensembl:	ENSG00000205581
Gene Name:	high mobility group nucleosome binding domain 1
Gene Alias:	HMG14
Gene Type:	protein-coding
CpG%:	0.300000
GC%:	0.727273
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@HMGN1 p2@HMGN1 p3@HMGN1 p4@HMGN1 p5@HMGN1 p6@HMGN1 p7@HMGN1 p9@HMGN1 p10@HMGN1
Sample		p1@HMGN1	p2@HMGN1	p3@HMGN1	p4@HMGN1	p5@HMGN1	p6@HMGN1	p7@HMGN1	p9@HMGN1	p10@HMGN1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	26.10	15.58	2.92	12.47	3.12	0.58	0.39	0.39	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	24.28	16.99	4.05	11.73	4.45	0.20	0.61	0.20	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	26.04	17.36	4.44	13.12	4.44	0.19	0.19	0.19	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	22.66	14.76	1.87	11.02	4.37	0.21	0.42	0.62	0.42
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	22.95	14.40	3.82	9.67	4.95	0.22	0.90	0.22	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	22.29	14.34	2.91	11.63	4.65	0.19	0.97	0.19	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	40.31	16.78	7.19	12.20	5.01	0.22	1.09	0.44	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	23.98	12.60	5.09	11.38	2.18	0.24	0.00	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	31.84	10.04	3.42	11.54	2.35	1.28	0.64	0.21	0.64
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	27.82	23.19	4.64	14.49	2.32	0.00	0.00	0.00	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	18.19	18.59	1.21	11.32	4.04	0.00	0.40	1.21	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	24.39	21.95	2.85	10.57	5.29	0.41	0.00	0.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	44.97	2.10	13.06	1.45	0.48	0.16	0.48	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	36.69	2.41	9.17	2.56	0.60	0.15	0.30	0.45	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	52.91	2.63	8.78	1.54	1.32	0.22	0.00	0.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	35.21	2.26	8.55	0.50	0.50	0.25	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	41.93	2.18	5.90	2.40	0.22	0.00	0.66	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	32.90	4.22	5.06	2.53	0.42	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	35.19	2.13	4.80	1.07	0.53	0.00	0.53	0.00	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	45.58	3.31	13.09	2.26	0.30	0.15	0.15	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	40.36	2.41	9.22	2.00	0.53	0.67	0.40	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	43.67	2.59	9.49	1.38	0.69	0.00	0.17	0.17	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	35.29	4.52	8.66	1.42	0.52	0.39	0.13	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	44.41	2.18	9.95	1.21	0.97	0.49	0.00	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	47.21	3.35	8.77	1.55	0.26	0.00	0.00	0.26	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	53.49	1.58	9.81	1.90	0.95	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	41.76	3.30	7.69	2.20	0.55	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	44.09	2.12	8.49	1.65	0.71	0.00	0.24	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	43.93	2.42	7.43	2.42	0.81	0.00	0.32	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	48.14	3.62	9.77	1.99	0.90	0.00	0.54	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	39.36	2.51	8.37	1.26	0.63	0.42	0.21	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	43.77	2.74	8.40	1.37	1.37	0.59	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	30.60	2.74	6.12	1.90	0.84	0.21	0.21	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	32.33	4.45	7.42	1.15	1.15	0.49	0.49	0.16	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	45.06	1.87	8.04	2.80	0.93	0.00	0.56	0.19	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	45.41	2.68	7.09	2.68	0.19	0.19	0.38	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	45.78	3.07	13.90	2.25	0.41	0.41	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	32.84	2.62	6.45	2.22	0.81	0.40	0.20	0.00	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	44.03	2.16	8.91	1.89	0.00	0.27	0.81	0.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	35.05	3.12	5.76	2.64	0.48	0.00	0.24	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	43.99	1.65	9.65	1.65	0.47	0.24	0.24	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	32.35	1.90	6.44	2.20	0.73	0.15	0.15	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	45.55	2.74	9.91	2.32	1.27	0.42	0.42	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	38.81	2.27	9.44	2.80	0.87	0.17	0.17	0.00	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	42.97	2.61	10.44	3.21	1.41	0.40	0.20	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	38.62	2.33	12.33	2.56	0.70	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	35.99	2.40	8.40	2.16	1.20	0.48	0.00	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	40.83	4.47	8.64	1.49	0.30	0.60	0.30	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	51.47	2.15	8.38	3.35	0.48	0.24	0.24	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	41.05	1.82	10.11	2.83	0.00	0.61	0.61	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	36.48	2.25	6.76	2.05	0.41	0.20	0.41	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	34.25	2.45	6.23	1.56	0.89	0.00	0.22	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	181.90	41.98	13.99	27.98	13.99	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	33.36	2.13	4.61	1.77	1.77	0.35	0.71	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	30.16	1.33	2.98	3.31	0.99	0.00	0.33	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	59.56	16.78	9.23	5.03	0.00	0.84	0.84	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	25.26	5.51	6.43	1.84	0.92	0.46	0.46	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	51.53	2.92	7.45	1.62	0.32	0.65	0.65	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	50.74	2.25	5.14	1.61	0.00	0.96	0.32	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	43.06	2.83	8.17	3.77	0.94	0.31	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	33.84	0.71	4.23	0.00	0.00	0.71	0.00	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	46.55	2.80	3.93	0.00	2.24	0.56	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	45.38	7.17	8.76	4.78	0.80	0.80	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	35.00	3.06	7.47	2.04	1.36	0.68	0.68	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	49.71	1.95	8.12	0.97	0.00	0.00	0.65	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	43.31	2.13	4.61	1.42	0.71	0.71	0.35	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	113.15	16.16	16.16	0.00	0.00	16.16	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	292.21	39.49	31.59	31.59	0.00	7.90	7.90	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	36.08	0.49	5.85	2.93	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	18.84	0.99	6.45	2.48	0.00	0.00	0.00	0.00	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	30.02	0.47	9.85	3.28	0.00	0.47	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	30.47	2.32	7.29	2.98	0.66	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	31.86	1.24	3.71	1.24	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	37.30	0.92	7.03	1.22	0.61	0.31	0.31	0.00	0.00
Adipocyte - breast, donor1	11376-118A8	14.10	3.64	2.38	1.27	2.53	0.48	0.16	0.00	0.32
Adipocyte - breast, donor2	11327-117E4	9.47	3.05	4.65	1.12	1.28	0.16	0.48	0.16	0.16
Adipocyte - omental, donor1	11473-119C6	18.45	4.58	2.93	4.58	2.67	0.25	0.64	0.51	0.38
Adipocyte - omental, donor2	11474-119C7	11.21	2.99	2.24	1.49	0.00	0.00	1.49	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	17.42	7.70	1.67	4.02	2.68	0.33	1.67	0.33	0.00
Adipocyte - perirenal, donor1	11476-119C9	15.95	3.83	1.28	1.28	3.19	0.64	0.00	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	16.49	1.10	4.40	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	8.58	1.35	3.61	2.26	1.35	0.00	0.00	0.45	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	10.60	1.39	5.21	1.56	0.17	0.00	0.00	0.17	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	36.18	2.15	7.82	2.74	0.59	0.78	0.59	0.00	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	28.83	1.80	4.12	1.03	0.77	0.26	0.26	0.00	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	33.17	2.23	4.46	1.67	0.28	0.00	0.28	0.84	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	35.27	0.59	5.88	1.76	1.18	1.76	0.59	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	35.55	2.73	7.88	1.69	1.13	0.32	0.40	0.40	0.32
Adipocyte differentiation, day08, donor2	13023-139D8	31.95	2.90	4.20	0.97	0.65	0.65	0.00	0.97	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	16.53	5.87	2.13	1.07	1.07	0.53	1.60	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	13.91	3.90	0.56	1.11	0.00	0.56	1.11	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	17.88	1.25	2.08	1.25	0.42	0.00	0.42	0.83	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	15.57	1.00	2.01	0.50	1.00	1.00	0.00	1.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	15.71	1.64	1.31	0.98	0.98	0.98	0.65	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	12.48	2.44	0.91	0.00	0.61	0.30	0.30	0.00	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	35.14	7.07	5.52	3.31	5.08	0.22	0.22	0.00	0.66
Alveolar Epithelial Cells, donor2	11590-120G6	12.55	0.72	0.72	0.36	1.43	0.00	0.36	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	16.77	2.40	2.40	0.00	1.20	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	39.94	7.02	7.56	5.94	2.70	0.36	0.18	0.36	0.54
Amniotic Epithelial Cells, donor2	11613-122A2	23.43	3.35	5.02	3.35	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	34.31	6.37	4.93	4.93	1.23	0.21	0.41	0.00	0.21
Anulus Pulposus Cell, donor1	11248-116E6	35.70	8.35	4.58	1.14	1.14	0.34	0.46	0.11	0.11
Anulus Pulposus Cell, donor2	11463-119B5	24.98	6.12	3.18	2.45	2.45	0.24	1.22	0.00	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	29.65	9.88	3.59	0.90	0.90	0.00	0.90	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	39.94	9.12	2.60	2.17	3.04	0.00	0.00	0.87	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	38.52	0.00	2.14	2.14	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	36.17	9.86	2.09	1.20	1.49	0.30	0.60	0.60	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	32.88	5.06	1.26	2.53	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	34.98	5.94	3.30	1.32	2.64	0.66	1.32	0.66	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	24.69	9.10	4.55	2.27	2.27	0.32	0.65	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	32.52	10.68	3.40	1.94	1.46	0.49	0.49	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	23.16	7.13	2.38	0.00	2.38	0.59	1.19	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	36.53	7.91	3.01	1.51	1.88	0.75	0.00	1.88	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	37.01	5.81	3.63	2.18	1.45	0.00	0.00	0.73	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	26.33	5.02	1.25	1.25	2.51	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	32.29	7.74	4.12	1.15	1.81	0.49	0.16	0.00	0.33
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	21.84	5.46	4.09	1.36	0.00	0.00	0.00	1.36	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	37.70	7.84	6.33	1.81	2.11	0.00	0.15	0.30	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	30.00	11.79	2.68	0.54	1.61	0.54	0.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	33.25	4.91	4.91	2.27	0.94	0.76	0.38	0.19	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	30.47	7.75	2.41	0.27	1.87	0.53	0.27	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	19.51	6.83	0.00	0.98	0.00	0.00	0.00	1.95	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	32.84	7.13	5.81	2.65	1.16	0.66	0.66	0.17	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	16.81	8.41	1.20	1.20	2.40	1.20	1.20	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	21.24	14.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	35.85	6.52	5.15	2.40	0.86	0.51	0.17	0.34	0.34
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	4.19	4.19	4.19	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	29.61	11.65	2.43	0.97	2.43	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	26.56	7.97	7.59	3.04	3.04	0.38	0.38	0.00	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	33.92	8.48	2.42	1.21	2.42	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	39.33	15.96	2.85	0.00	2.28	0.57	0.00	0.57	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	27.58	6.84	5.99	1.71	1.71	0.64	0.21	0.00	0.43
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	36.39	7.48	4.90	1.55	2.32	0.26	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	33.78	8.45	2.35	0.94	0.94	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	33.76	8.04	5.14	1.93	1.29	0.64	0.32	0.32	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	27.82	5.71	2.14	3.57	4.28	0.71	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	31.00	14.62	1.75	1.17	1.75	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	28.60	8.13	3.61	1.51	2.41	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	34.45	8.32	5.94	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	27.46	7.63	4.07	1.53	2.03	0.00	1.53	1.02	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	29.80	10.19	4.58	1.53	2.80	0.25	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	24.78	6.35	2.54	1.27	0.64	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	34.95	6.90	3.88	1.29	0.86	0.00	0.43	0.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	34.08	8.26	4.87	0.64	0.85	1.06	0.21	0.00	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	24.36	8.99	2.32	0.87	1.16	0.29	0.29	0.29	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	27.40	13.23	6.61	3.78	1.89	0.94	0.94	0.00	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	31.36	9.83	4.58	1.70	1.19	0.85	0.34	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	11.58	11.58	0.00	0.00	2.32	0.00	0.00	2.32	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	19.01	10.56	0.00	0.00	2.11	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	30.45	9.01	3.65	0.86	1.50	0.00	0.64	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	30.68	7.22	2.41	1.20	3.01	0.60	0.00	0.00	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	30.62	9.48	2.92	0.73	0.73	0.00	0.00	0.73	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	31.49	8.97	2.99	1.61	2.30	0.23	0.00	0.46	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	25.50	10.20	0.00	2.55	2.55	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	26.44	8.39	3.56	1.27	1.02	0.00	0.25	0.00	1.27
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	36.13	5.78	6.40	2.06	1.45	0.41	0.21	1.03	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	27.54	6.12	2.45	0.61	0.92	0.00	0.00	0.31	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	26.77	9.56	0.96	2.87	1.91	0.48	0.48	0.48	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	29.93	6.43	4.66	2.44	1.11	0.00	0.22	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	27.46	3.05	1.53	1.53	1.53	0.00	0.00	0.00	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	27.14	9.97	1.11	1.11	1.11	1.11	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	34.16	7.41	3.97	1.32	2.12	0.00	0.00	1.32	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	33.80	7.27	2.91	1.82	2.54	0.36	0.36	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	33.53	12.65	3.32	3.68	6.88	0.61	1.35	0.12	0.00
Astrocyte - cerebellum, donor2	11580-120F5	41.25	4.45	3.25	6.50	2.40	0.51	0.17	0.00	0.17
Astrocyte - cerebellum, donor3	11661-122F5	21.60	2.10	3.36	2.94	1.26	0.63	0.21	0.21	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	54.73	27.19	8.37	8.37	7.67	0.35	1.05	0.00	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	76.52	40.93	25.07	5.82	5.34	0.81	0.97	0.16	0.32
Astrocyte - cerebral cortex, donor3	11392-118C6	68.46	27.15	30.43	5.82	4.03	1.94	1.04	0.30	0.75
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	75.00	6.42	45.87	8.60	2.41	0.92	1.26	0.57	0.11
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	83.69	7.39	44.48	9.52	2.76	1.50	2.00	0.13	0.75
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	76.36	7.28	43.58	11.38	2.84	1.02	0.91	1.14	0.34
Basophils, donor1	12241-129G9	14.65	6.02	2.09	2.35	1.83	0.52	0.26	1.31	0.52
Basophils, donor2	12242-129H1	33.19	13.35	8.30	5.77	4.33	0.36	1.08	2.89	1.08
Basophils, donor3	12243-129H2	39.10	8.53	8.23	4.26	2.79	0.73	0.44	1.32	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	10.13	1.08	3.45	1.29	0.43	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	7.77	0.46	0.46	0.91	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	14.35	0.00	7.17	7.17	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	21.97	10.04	1.88	4.39	0.63	0.00	0.00	0.63	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	22.46	2.70	1.46	3.12	0.42	0.21	0.00	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	16.12	2.07	2.07	2.53	0.23	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	17.99	2.70	12.06	5.94	0.90	0.00	0.00	0.00	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	196.84	32.87	38.44	31.53	20.40	4.84	5.36	0.82	1.65
Burkitt's lymphoma cell line:RAJI	10476-106I8	164.43	20.96	22.59	14.91	5.82	3.03	4.19	0.00	1.63
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	131.75	12.79	24.94	16.31	6.40	2.88	2.88	0.32	1.28
CD133+ stem cells - cord blood derived, pool1	12223-129E9	103.42	41.37	10.34	20.68	10.34	0.00	10.34	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	17.47	7.89	1.69	1.69	1.13	1.13	0.56	1.13	0.00
CD14+ Monocytes, donor2	11305-117B9	22.27	7.24	3.53	0.74	0.93	1.11	0.19	1.67	0.00
CD14+ Monocytes, donor3	11381-118B4	18.44	5.93	7.46	1.76	1.10	0.22	0.88	0.88	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	35.66	5.38	4.81	2.26	1.70	0.00	0.57	1.13	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	26.54	4.93	5.69	1.90	0.38	1.14	0.76	1.52	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	25.64	1.64	7.89	1.97	1.31	0.66	0.00	0.33	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	14.17	4.48	2.60	2.02	1.16	0.58	0.29	0.29	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	14.48	5.43	1.21	2.11	0.60	0.30	0.30	0.60	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	16.35	5.21	0.95	1.66	1.42	0.71	0.00	0.71	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	11.05	3.18	1.84	1.34	0.67	0.17	0.17	0.67	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	9.94	4.97	0.83	3.04	0.83	0.28	0.55	1.10	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	13.14	7.69	2.23	2.23	1.49	0.50	0.25	1.24	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	13.90	3.13	2.35	0.78	0.20	0.59	0.00	0.20	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	13.89	3.38	2.14	0.89	1.25	0.00	0.53	0.00	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	16.76	7.40	1.74	0.65	1.31	0.22	0.22	0.44	0.44
CD14+ monocytes - treated with Candida, donor1	11868-125B5	8.90	2.81	0.94	0.70	0.47	0.70	0.23	0.47	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	16.90	7.92	0.53	2.11	1.58	0.53	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	18.86	4.44	1.11	1.11	2.22	0.00	1.11	2.22	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	9.82	5.65	2.83	1.78	0.45	0.15	0.15	0.74	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	13.97	5.39	1.60	1.00	1.40	0.80	0.00	0.40	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	18.74	8.74	2.50	2.08	2.29	0.42	0.21	0.42	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	9.84	4.12	1.60	0.92	0.69	0.00	0.23	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	10.41	8.60	0.90	1.13	1.13	0.23	0.00	0.68	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	10.48	8.73	2.18	1.31	3.49	0.00	0.44	1.31	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	9.41	4.57	1.61	1.08	0.81	0.00	0.00	1.08	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	15.00	4.71	1.92	0.87	0.35	0.35	0.52	0.87	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	9.68	4.63	1.68	1.26	0.00	0.42	0.00	0.00	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	10.10	3.67	1.29	0.92	0.73	0.37	0.18	0.55	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	9.86	4.93	1.76	0.35	1.41	0.00	0.70	0.70	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	10.97	3.51	3.51	0.88	1.32	0.00	0.00	0.44	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	9.59	3.84	0.52	1.05	0.35	0.70	0.00	0.87	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	10.41	3.35	2.23	1.86	0.00	0.00	0.00	0.37	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	12.50	9.48	2.16	1.51	2.37	0.43	0.43	0.86	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	9.83	2.87	0.82	0.82	0.00	0.00	0.00	0.00	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	8.81	5.33	0.93	1.85	0.93	0.46	0.46	0.70	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	9.05	4.64	1.86	1.86	1.39	0.70	0.23	0.23	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	15.48	4.36	1.31	2.18	0.87	0.22	0.00	1.09	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	14.55	8.78	1.85	0.92	1.39	0.00	0.46	0.69	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	12.56	6.28	1.30	0.43	1.73	0.65	0.00	0.65	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	34.10	9.03	4.52	1.56	2.96	0.47	0.16	1.71	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	17.46	9.43	1.57	1.40	1.22	0.35	0.52	0.87	0.52
CD14+CD16- Monocytes, donor3	11910-125G2	16.05	11.15	0.67	2.01	1.56	0.67	0.45	0.67	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	18.88	5.87	2.81	2.04	1.02	0.77	0.77	3.83	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	10.54	9.44	0.66	1.10	2.20	0.44	0.00	1.98	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	9.69	9.05	2.32	0.63	2.32	0.84	0.00	1.47	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	79.26	4.06	16.26	0.00	2.03	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	86.78	2.03	14.24	1.36	0.00	0.68	0.00	0.68	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	93.20	4.14	11.39	5.18	2.07	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	97.55	6.93	20.26	0.53	1.60	0.53	1.60	0.53	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	112.57	4.82	24.66	1.07	0.54	1.07	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	92.66	3.51	20.36	2.81	1.40	0.00	1.40	0.70	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	100.40	4.71	14.90	0.00	0.78	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	112.05	5.27	13.18	5.27	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	79.72	2.47	13.97	5.75	0.82	0.00	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	71.82	4.35	10.16	0.73	1.45	0.73	0.73	0.73	0.00
CD19+ B Cells, donor3	11705-123B4	81.78	4.04	11.61	1.51	1.51	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	33.94	10.51	6.87	3.64	5.66	0.00	1.21	4.44	0.81
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	32.36	7.19	5.99	1.20	5.59	0.80	1.20	4.39	0.40
CD34+ Progenitors, donor1	11545-120B6	71.29	10.04	8.03	5.02	2.01	2.01	3.01	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	52.25	16.85	4.49	4.49	5.62	0.56	2.25	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	127.38	12.40	34.19	18.04	10.15	3.38	1.50	0.00	0.75
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	139.80	18.72	32.24	16.91	6.54	4.51	3.61	0.00	1.58
CD4+ T Cells, donor1	11225-116C1	59.99	0.71	12.50	5.36	1.07	0.36	0.71	0.00	0.36
CD4+ T Cells, donor2	11306-117C1	45.31	1.22	9.19	0.61	1.22	0.61	0.61	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	55.20	2.13	14.33	4.57	1.22	0.30	0.61	0.30	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	59.73	4.59	5.10	3.57	1.28	0.26	0.26	0.26	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	57.95	2.47	6.29	4.72	1.35	0.22	0.67	0.22	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	50.02	4.89	4.60	1.44	0.86	0.00	0.86	0.29	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	86.76	1.42	17.07	8.06	0.47	0.47	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	101.13	3.51	15.45	14.05	0.00	1.40	0.00	0.70	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	56.04	0.00	16.48	6.59	3.30	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	56.51	6.07	4.48	5.93	0.87	0.87	0.43	0.58	0.14
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	64.06	3.73	14.23	5.76	1.19	0.51	1.02	0.17	0.51
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	55.45	5.80	8.54	8.38	1.29	0.00	0.16	0.16	0.32
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	50.21	4.48	9.41	9.86	3.14	1.34	0.45	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	55.90	4.89	4.54	6.64	1.05	0.35	1.05	0.70	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	41.80	3.52	7.04	6.16	2.20	0.00	0.00	0.00	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	51.02	2.95	1.69	5.06	0.84	0.42	0.42	0.42	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	73.97	2.08	17.66	6.44	1.04	0.00	0.83	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	56.47	1.67	9.02	4.68	0.00	0.00	0.33	0.33	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	67.71	0.82	11.15	5.44	0.00	0.00	0.27	0.54	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	66.99	1.61	8.58	8.04	0.00	0.54	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	68.14	0.00	8.97	5.38	1.79	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	77.88	5.38	6.12	5.01	2.60	0.37	0.37	0.56	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	60.87	4.77	12.78	6.28	2.60	1.08	0.43	0.22	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	49.81	3.36	8.20	5.46	0.84	0.42	0.21	0.21	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	79.38	2.02	10.62	13.15	1.01	0.00	1.01	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	78.85	2.17	11.70	5.63	0.87	0.00	0.43	0.87	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	61.89	4.36	8.28	4.36	2.61	0.00	0.44	0.44	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	76.70	2.97	19.30	4.45	0.99	0.49	0.00	0.00	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	54.47	1.85	7.39	6.46	0.92	0.92	0.92	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	78.17	2.79	13.96	9.77	2.79	2.79	1.40	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	52.34	5.54	4.43	4.71	2.49	0.00	0.83	0.55	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	58.65	5.64	4.17	7.36	1.72	0.74	0.74	0.25	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	35.42	3.08	9.24	3.08	0.00	0.00	0.00	1.54	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	58.37	5.37	16.12	4.66	3.22	0.36	0.36	0.00	0.72
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	54.01	5.54	16.62	9.69	0.00	2.77	1.38	1.38	0.00
CD8+ T Cells, donor1	11226-116C2	34.70	5.89	10.15	8.51	0.98	0.98	0.98	0.65	0.00
CD8+ T Cells, donor2	11307-117C2	35.29	6.01	7.88	1.13	1.50	1.50	1.13	1.50	0.75
CD8+ T Cells, donor3	11383-118B6	48.48	4.29	15.91	4.54	1.26	2.27	0.50	1.26	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	10.32	6.42	1.15	7.11	0.92	0.69	0.23	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	9.11	5.27	1.20	4.79	1.44	0.72	0.72	0.24	0.48
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	8.75	4.65	4.38	3.56	2.74	0.27	0.55	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	7.51	5.40	1.20	8.11	2.10	0.00	0.00	0.30	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	6.24	4.32	1.44	4.56	1.68	0.00	0.00	0.00	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	11.14	4.78	0.91	6.82	2.27	0.45	0.00	0.23	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	9.34	7.39	1.96	8.26	2.39	0.43	0.87	0.00	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	7.90	8.95	0.79	8.95	2.63	0.00	0.53	0.00	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	6.80	7.50	0.94	8.21	3.05	0.70	0.00	0.00	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	8.15	12.08	1.51	8.75	3.92	0.00	0.60	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	7.26	10.75	1.45	7.84	2.03	0.00	0.58	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	7.19	11.72	2.40	10.92	5.06	0.80	1.07	0.00	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	3.50	8.76	0.00	6.13	2.63	0.00	0.00	0.44	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	5.47	14.12	1.37	9.11	2.28	0.00	0.91	0.46	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	8.20	8.20	0.00	7.46	2.24	0.75	0.75	0.00	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	7.56	5.40	1.44	5.76	1.44	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	9.78	7.19	2.01	5.47	0.86	0.58	0.29	0.00	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	8.72	4.71	3.06	3.54	1.65	0.24	0.00	0.24	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	4.75	7.61	2.54	7.92	2.54	0.63	0.32	0.00	0.63
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	6.46	10.46	1.23	8.30	1.23	0.31	0.92	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	9.30	4.17	1.60	5.77	2.24	0.32	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	9.18	12.24	1.53	12.62	3.06	0.38	0.38	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	7.49	9.06	0.39	5.52	2.36	0.79	0.79	0.39	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	4.54	7.56	2.27	7.56	1.51	0.00	0.00	0.00	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	8.83	17.67	2.41	7.23	1.61	0.00	0.80	0.80	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	9.09	18.19	2.10	5.60	3.50	0.70	0.70	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	5.01	16.03	2.00	6.01	6.01	1.00	4.01	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	3.66	9.14	0.00	14.62	1.83	1.83	0.00	0.00	1.83
Cardiac Myocyte, donor2	11605-120I3	30.14	6.42	12.85	6.42	0.49	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	29.89	4.10	15.15	5.37	1.26	0.11	0.21	0.11	0.11
Chondrocyte - de diff, donor1	11261-116G1	26.00	4.85	2.77	6.93	1.73	0.35	1.39	0.00	0.35
Chondrocyte - de diff, donor2	11338-117F6	7.11	2.49	1.78	2.13	1.07	0.71	0.00	0.00	0.36
Chondrocyte - de diff, donor3	11410-118E6	32.09	2.84	10.47	3.53	0.46	0.46	0.34	0.00	0.11
Chondrocyte - re diff, donor2	11339-117F7	25.07	2.69	4.48	6.27	3.58	0.90	0.90	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	27.10	2.02	9.30	1.21	0.00	0.00	0.00	0.81	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	49.58	23.98	16.30	6.54	4.48	1.95	0.92	0.11	0.34
Ciliary Epithelial Cells, donor2	11323-117D9	42.11	9.41	19.45	3.85	2.78	1.71	1.07	0.21	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	41.68	13.19	23.01	11.42	4.07	1.77	0.62	0.18	0.71
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	24.76	7.43	4.95	1.93	4.31	1.65	2.11	3.85	1.19
Corneal Epithelial Cells, donor1	11526-119I5	12.95	0.44	2.85	5.05	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	7.96	1.14	2.28	4.55	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	21.73	2.30	6.65	5.11	1.28	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	25.09	3.96	9.08	6.77	1.32	0.33	0.33	0.66	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	31.54	4.42	6.62	9.15	3.15	0.32	0.00	1.58	0.95
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	17.25	0.00	6.90	0.00	0.00	0.00	3.45	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	17.93	3.46	12.53	3.24	1.08	0.54	0.65	0.76	0.11
Dendritic Cells - plasmacytoid, donor1	11228-116C4	73.45	10.25	8.88	5.81	5.12	1.71	5.81	0.68	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	71.82	12.40	15.67	15.02	3.92	1.96	5.22	0.00	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	67.75	11.61	2.42	13.07	5.32	3.39	4.84	0.48	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	47.53	10.17	5.34	0.50	3.50	0.83	0.17	0.17	0.33
Endothelial Cells - Aortic, donor1	11263-116G3	31.10	7.04	1.76	1.17	3.52	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	47.51	10.75	4.52	3.96	2.26	0.00	0.00	0.00	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	33.81	12.58	4.72	1.57	1.97	0.00	0.39	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	32.87	6.98	5.24	1.45	0.87	0.29	0.00	0.00	0.29
Endothelial Cells - Artery, donor2	11341-117F9	50.35	13.88	11.76	4.00	2.82	0.71	0.24	0.24	0.47
Endothelial Cells - Artery, donor3	11413-118E9	34.36	10.17	8.06	2.63	2.63	0.88	0.53	0.18	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	39.01	15.29	3.99	2.22	1.99	0.00	0.22	0.22	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	32.86	11.26	7.61	2.13	3.04	1.22	0.00	0.30	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	31.01	20.58	3.10	1.13	5.64	0.85	0.85	0.28	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	15.75	6.24	0.59	0.59	3.57	0.00	0.00	0.00	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	24.47	8.33	1.56	2.08	4.17	0.52	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	31.76	2.84	4.68	0.43	1.13	0.43	0.14	0.28	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	38.41	22.41	0.80	4.00	6.80	0.00	0.00	0.40	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	26.21	8.91	1.05	1.57	1.57	0.52	0.52	0.52	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	104.62	36.03	14.04	2.86	6.96	1.62	0.37	0.12	0.37
Endothelial Cells - Umbilical vein, donor2	11324-117E1	106.24	24.55	26.51	3.04	5.87	0.87	0.87	0.43	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	107.23	24.43	27.23	5.37	5.50	1.83	0.24	0.12	0.98
Endothelial Cells - Vein, donor1	11267-116G7	23.89	14.79	4.55	2.28	5.69	1.14	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	20.26	13.97	2.79	1.40	1.40	0.00	0.70	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	50.09	16.80	15.07	1.10	2.51	0.94	0.47	0.16	1.26
Eosinophils, donor1	12244-129H3	30.49	0.00	0.00	0.00	0.00	0.00	15.25	0.00	0.00
Eosinophils, donor2	12245-129H4	52.81	11.55	13.20	0.00	1.65	0.00	0.00	1.65	0.00
Eosinophils, donor3	12246-129H5	10.70	0.00	10.70	7.13	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	17.59	1.71	3.91	1.22	1.47	0.00	0.00	0.00	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	4.16	2.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	27.09	3.28	7.39	8.21	0.82	0.00	0.82	0.41	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	11.17	2.74	2.74	1.09	1.09	0.11	0.11	0.55	0.11
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	38.13	2.71	5.42	2.49	0.54	0.11	0.11	0.00	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	37.48	7.03	7.76	4.73	2.06	0.12	0.61	0.49	0.24
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	10.24	7.64	5.05	3.00	1.36	0.55	0.14	1.77	0.00
Fibroblast - Aortic Adventitial, donor2	11326-117E3	15.71	5.38	6.64	1.37	1.27	0.21	0.00	0.21	0.11
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	17.39	5.27	1.58	1.58	0.26	0.00	0.00	1.32	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	45.84	5.98	12.96	2.33	2.33	1.33	0.00	0.66	0.33
Fibroblast - Cardiac, donor1	11268-116G8	23.13	6.35	7.26	9.07	1.36	0.45	0.91	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	18.19	6.06	1.52	3.03	0.76	0.00	2.27	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	21.29	3.31	7.57	2.84	0.95	0.32	0.63	0.16	0.32
Fibroblast - Cardiac, donor4	11452-119A3	29.40	6.67	10.31	3.33	2.73	0.91	0.61	0.30	0.61
Fibroblast - Cardiac, donor5	11456-119A7	48.10	11.80	4.95	3.93	2.41	0.13	0.51	0.13	0.25
Fibroblast - Cardiac, donor6	11460-119B2	45.02	12.89	7.12	3.49	2.88	0.45	0.76	0.00	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	20.90	5.23	1.61	3.22	0.94	0.40	0.13	0.13	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	14.67	6.47	5.18	6.47	0.43	0.43	0.00	0.43	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	30.76	10.25	4.39	2.93	1.46	1.46	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	39.44	3.23	8.53	5.54	2.08	0.69	0.69	0.46	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	29.68	10.52	5.26	1.53	2.04	0.85	0.51	0.17	0.17
Fibroblast - Dermal, donor1	11269-116G9	32.40	4.23	6.34	6.10	2.58	0.70	0.00	0.00	0.23
Fibroblast - Dermal, donor2	11346-117G5	20.28	5.19	2.83	2.36	1.42	0.47	0.47	0.47	0.00
Fibroblast - Dermal, donor3	11418-118F5	19.70	2.90	8.22	3.51	0.85	0.36	0.24	0.24	0.12
Fibroblast - Dermal, donor4	11450-119A1	66.13	13.68	7.57	5.54	3.50	2.26	1.47	0.11	0.57
Fibroblast - Dermal, donor5	11454-119A5	57.74	13.78	6.80	5.06	5.93	1.22	1.92	0.17	0.87
Fibroblast - Dermal, donor6	11458-119A9	59.93	16.73	6.33	5.68	6.82	1.95	3.41	0.16	0.81
Fibroblast - Gingival, donor1	11237-116D4	41.44	5.00	7.29	4.37	0.83	0.21	1.04	0.42	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	41.92	2.88	10.22	6.29	0.52	0.00	0.52	0.79	0.00
Fibroblast - Gingival, donor2	11318-117D4	96.73	22.67	27.15	8.96	6.59	3.43	1.58	0.26	1.32
Fibroblast - Gingival, donor3	11394-118C8	42.35	6.38	10.93	2.03	0.77	0.10	0.19	0.19	0.10
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	22.86	4.16	3.12	5.19	1.04	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	19.73	1.59	5.11	1.94	0.35	0.18	0.00	0.18	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	50.98	4.05	11.69	7.95	1.40	0.47	1.25	0.16	0.00
Fibroblast - Gingival, donor6 (control)	11922-125H5	40.16	4.19	7.98	3.92	2.30	0.68	0.81	0.00	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	30.70	1.41	3.18	0.71	0.35	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	50.60	3.22	9.80	5.26	1.75	0.58	0.44	0.29	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	47.31	4.36	7.64	5.32	2.18	0.27	0.27	0.14	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	53.09	6.69	9.98	7.79	2.52	0.66	1.54	0.33	0.33
Fibroblast - Gingival, donor9 (control)	11927-125I1	37.42	3.82	6.90	4.26	1.32	0.59	0.59	0.29	0.00
Fibroblast - Lung, donor1	11270-116H1	12.23	4.08	2.72	5.44	1.36	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	20.89	16.41	13.43	2.98	5.97	2.98	1.49	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	54.66	9.71	14.77	2.74	1.90	2.11	1.90	0.42	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	20.83	2.50	1.67	2.50	0.83	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	20.98	0.00	1.40	1.40	1.40	1.40	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	7.84	1.12	0.28	1.12	0.28	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	26.79	2.84	5.68	4.47	0.81	0.41	0.41	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	27.96	0.00	7.99	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	29.78	0.00	5.96	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	67.31	17.26	12.03	3.49	7.76	2.33	1.36	0.58	1.16
Fibroblast - Periodontal Ligament, donor2	11319-117D5	85.55	12.59	21.99	7.43	5.16	2.88	2.58	0.46	0.91
Fibroblast - Periodontal Ligament, donor3	11395-118C9	36.72	5.81	8.57	4.90	2.45	0.00	0.31	1.22	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	33.96	2.67	10.69	9.16	1.14	0.76	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	29.16	2.43	8.64	3.51	0.81	0.00	0.27	0.27	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	25.05	2.20	6.38	2.90	0.81	0.35	0.00	0.12	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	39.35	14.70	11.50	7.85	2.98	1.44	0.88	0.22	0.22
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	32.10	3.25	6.71	3.05	0.61	1.22	0.41	0.20	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	33.41	5.35	6.68	2.00	0.00	0.67	0.67	0.00	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	38.35	2.77	12.26	3.16	0.40	1.58	0.40	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	17.86	4.37	2.38	1.59	1.39	0.40	0.79	0.40	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	21.67	3.55	4.09	3.73	1.24	0.89	0.36	0.36	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	20.69	4.34	5.91	4.53	1.58	0.59	0.39	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	11.73	3.01	2.71	2.71	1.20	0.00	1.20	0.30	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	25.15	4.86	1.94	6.15	1.19	0.86	0.54	0.00	0.11
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	15.44	1.27	1.77	3.29	1.01	0.00	0.25	1.27	0.00
Fibroblast - skin normal, donor1	11553-120C5	20.35	1.97	4.10	5.58	0.49	0.00	0.16	0.16	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	22.86	5.21	9.02	4.21	1.60	0.60	0.20	0.80	0.00
Fibroblast - skin normal, donor2	11561-120D4	25.42	6.23	2.71	4.72	2.21	0.60	0.80	0.30	0.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	16.93	3.32	3.63	4.53	1.81	0.00	0.60	1.21	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	32.97	4.23	3.56	4.56	1.49	0.50	0.33	0.17	0.17
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	20.69	6.67	1.54	3.08	1.71	0.00	1.03	0.17	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	19.05	3.61	2.63	0.99	1.31	0.00	0.00	0.33	0.66
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	33.23	7.35	2.98	5.86	2.77	0.64	0.75	0.11	0.11
Fibroblast - skin walker warburg, donor1	11554-120C6	35.42	7.08	6.41	4.89	2.70	1.52	0.51	0.00	0.34
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	29.33	2.98	9.25	6.43	0.16	0.47	0.31	0.00	0.16
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	199.44	155.12	66.48	22.16	0.00	44.32	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	26.15	5.23	6.10	4.36	0.00	0.00	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	34.84	9.01	5.55	2.60	1.39	0.35	0.52	0.17	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	44.24	10.93	12.75	3.38	1.56	0.00	0.52	0.00	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	39.09	7.67	9.96	3.58	2.30	0.51	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	102.58	65.84	11.48	11.48	6.89	2.30	0.00	0.00	1.53
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	110.39	91.24	7.66	18.50	14.68	2.55	3.83	0.00	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	218.80	123.23	65.61	15.40	25.39	6.28	3.42	0.00	2.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	214.26	37.23	75.01	6.34	4.41	0.55	0.83	0.55	0.55
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	124.89	38.36	50.69	11.64	7.08	1.37	1.14	0.68	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	200.71	79.05	63.01	10.50	15.45	4.36	1.59	0.99	2.58
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	204.07	35.16	69.26	4.76	4.76	0.53	0.26	0.79	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	120.35	26.42	56.42	13.37	7.83	2.28	0.65	0.65	0.98
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	170.26	112.77	21.67	16.80	16.36	2.21	1.77	0.44	2.21
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	73.20	70.52	9.33	5.94	7.49	0.42	1.13	0.42	0.14
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	70.31	46.18	12.56	6.77	5.17	1.48	1.23	0.37	0.74
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	56.95	41.10	21.49	5.37	8.06	0.81	0.81	1.07	0.81
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	76.44	36.42	11.77	3.84	4.71	1.24	0.87	0.37	0.62
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	60.77	34.05	6.92	3.60	5.54	1.11	0.69	0.00	0.55
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	43.30	29.07	15.25	3.05	3.86	0.61	0.41	0.41	0.61
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	52.25	17.80	13.46	2.05	2.74	0.91	0.23	0.00	0.68
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	65.15	24.41	8.60	3.24	4.48	0.37	0.25	0.25	0.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	60.76	19.23	15.52	1.97	3.28	1.75	0.22	0.00	1.09
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	51.12	23.34	14.77	3.55	4.14	2.07	0.00	0.00	0.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	63.90	32.43	7.31	3.66	4.61	0.79	0.95	0.16	0.95
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	54.96	19.44	18.54	1.56	3.80	0.67	1.34	0.22	0.67
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	50.41	18.75	16.13	3.43	2.82	0.81	0.60	0.00	0.40
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	61.92	31.38	9.67	6.62	5.60	1.53	1.36	0.00	0.51
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	57.64	25.89	8.78	4.26	6.12	1.15	0.53	0.00	0.27
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	45.16	17.38	8.32	2.08	4.16	0.83	1.04	0.00	0.31
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	34.84	17.93	4.27	2.05	4.95	0.51	0.51	0.34	0.34
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	62.63	24.68	13.28	4.09	3.87	1.22	1.00	0.11	0.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	49.00	21.22	8.49	5.32	4.91	1.08	0.92	0.33	0.58
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	38.18	25.11	4.49	4.49	6.13	1.84	1.02	0.00	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	51.99	16.71	14.44	1.24	2.68	1.24	1.24	0.00	0.83
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	60.64	23.87	9.68	3.11	3.69	1.38	1.38	0.23	0.46
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	43.69	17.84	14.18	2.84	3.00	0.67	0.33	0.00	0.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	39.46	12.34	12.12	2.20	2.20	0.44	0.88	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	57.68	25.09	11.56	3.44	3.69	0.98	1.23	0.12	0.49
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	40.52	15.56	17.83	3.40	1.95	1.46	0.65	0.16	0.65
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	36.24	12.83	8.66	0.64	3.21	0.64	0.64	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	46.05	17.06	8.43	1.90	2.84	1.99	1.04	0.19	0.47
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	34.80	8.07	10.60	1.58	1.90	0.63	0.32	0.00	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	31.02	13.08	9.43	2.74	2.43	0.61	0.61	0.30	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	45.68	20.59	10.04	2.82	4.18	1.88	1.25	0.42	0.31
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	22.39	7.68	8.78	2.42	3.29	0.88	0.66	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	36.19	12.34	10.38	2.24	3.93	1.12	0.56	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	33.70	13.05	3.24	4.26	3.89	0.65	0.93	0.19	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	21.66	10.70	6.69	2.94	2.67	1.07	0.53	0.00	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	30.75	13.01	9.03	2.91	2.91	1.84	1.22	0.15	0.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	38.08	17.23	7.77	4.15	2.72	1.04	1.42	0.13	0.13
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	25.48	11.39	7.86	0.54	2.98	0.54	1.63	0.00	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	30.60	14.56	8.30	2.58	3.50	1.47	0.55	0.00	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	27.85	12.50	9.65	2.63	3.95	1.32	1.54	0.44	0.66
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	29.75	13.88	4.96	2.98	2.98	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	33.64	14.51	8.57	3.69	3.17	1.58	1.32	0.13	0.13
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	34.10	11.10	8.07	3.23	3.23	1.82	0.81	0.00	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	15.25	9.15	4.83	1.78	2.80	1.02	0.51	0.00	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	66.09	91.17	3.58	7.37	17.32	2.79	2.39	0.80	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	73.49	59.01	13.40	4.01	8.32	1.08	1.39	0.92	0.31
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	96.77	98.81	5.73	5.11	10.02	0.82	2.25	0.41	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	92.63	65.40	16.59	16.27	10.01	0.94	0.94	0.00	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	94.94	63.57	14.69	13.56	12.43	1.98	1.98	0.00	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	61.80	80.25	5.07	13.84	10.15	0.92	0.00	0.46	1.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	86.62	51.97	9.90	19.80	22.27	4.95	0.00	0.00	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	83.16	54.54	11.60	12.76	7.35	1.93	0.77	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	27.28	51.34	8.02	24.07	16.04	1.60	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	85.20	45.21	24.34	27.82	12.17	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	91.13	34.83	16.27	15.95	11.07	2.28	1.63	0.00	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	83.18	44.06	9.06	15.24	11.12	1.24	0.41	0.00	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	113.30	23.33	10.00	6.66	10.00	0.00	0.00	0.00	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	89.49	36.07	12.30	12.30	5.87	1.40	1.12	0.28	1.12
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	80.40	36.28	10.46	11.11	7.84	1.63	1.31	0.00	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	67.11	31.04	22.65	11.74	4.19	0.84	1.68	0.00	2.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	97.01	37.85	16.22	11.77	11.13	0.64	0.95	0.00	0.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	86.61	37.02	12.23	12.23	7.47	2.04	1.36	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	110.67	43.85	20.88	12.53	16.71	2.09	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	107.67	41.23	10.88	8.02	6.30	1.15	0.57	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	78.14	20.13	11.54	5.33	5.92	1.18	1.18	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	127.06	40.66	23.72	18.64	5.08	0.00	3.39	0.00	3.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	100.65	37.69	14.50	16.15	7.87	1.66	0.83	0.00	0.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	95.73	34.29	23.93	15.19	7.13	1.38	0.69	0.00	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	105.37	47.42	21.07	15.81	10.54	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	80.73	27.68	5.77	7.69	7.30	0.77	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	91.27	26.08	13.36	13.69	3.26	0.65	0.33	0.00	1.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	143.13	30.77	26.75	10.03	7.36	3.34	0.00	0.00	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	97.86	36.99	9.63	3.85	4.62	0.77	0.77	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	101.67	24.99	14.38	11.64	7.53	1.37	0.34	0.00	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	114.30	7.45	12.42	9.94	2.48	2.48	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	124.57	29.73	25.48	2.36	6.13	0.00	0.94	0.00	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	98.37	25.35	14.48	3.02	1.81	0.00	0.00	0.00	1.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	107.84	27.47	16.28	7.12	3.56	1.02	1.53	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	101.31	23.93	17.15	7.98	4.79	0.00	1.20	0.40	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	86.83	19.73	12.83	6.41	8.88	0.00	0.49	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	99.16	36.59	7.08	3.54	9.44	1.18	1.18	0.00	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	104.44	28.01	21.00	5.25	9.92	0.58	0.58	0.58	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	81.63	24.14	7.90	2.19	5.27	0.88	0.88	0.44	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	55.95	21.19	10.17	4.24	3.39	0.85	0.85	0.85	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	69.24	12.54	10.15	9.55	5.37	0.00	1.19	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	66.48	14.07	10.68	9.22	3.88	0.00	0.97	0.49	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	19.40	4.57	4.57	2.28	0.00	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	20.79	2.08	7.48	1.25	0.00	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	23.61	2.25	6.75	2.25	0.00	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	12.69	3.49	3.49	1.90	0.63	0.32	0.00	0.63	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	12.11	5.01	5.01	2.51	0.84	0.00	0.42	0.84	0.84
Hep-2 cells mock treated, biol_rep1	11898-125E8	52.33	9.86	10.33	6.38	3.48	0.81	0.81	0.00	0.35
Hep-2 cells mock treated, biol_rep2	11899-125E9	42.20	10.80	10.47	4.73	4.05	0.84	1.18	0.00	0.51
Hep-2 cells mock treated, biol_rep3	11900-125F1	50.96	8.19	10.01	7.51	2.05	0.46	0.00	0.46	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	56.18	10.38	10.49	5.57	3.39	1.20	0.77	0.11	0.44
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	47.50	11.18	7.74	6.66	3.01	0.86	1.07	0.43	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	43.49	6.67	7.32	6.03	4.52	0.86	1.72	0.22	0.43
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	52.80	10.59	9.59	4.36	3.49	0.62	0.50	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	42.89	8.06	5.32	4.63	2.40	0.51	1.03	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	40.69	6.73	8.97	3.84	2.56	0.64	0.96	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	47.01	8.95	3.36	1.68	1.68	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	32.89	2.60	3.03	0.87	1.30	0.43	0.00	0.00	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	7.93	10.58	5.29	0.00	2.64	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	28.92	1.06	6.35	3.88	3.17	0.71	0.71	0.00	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	18.16	2.91	2.18	1.45	0.73	0.73	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	42.84	11.01	12.24	10.49	2.97	0.87	1.22	0.00	0.17
Hepatocyte, donor1	11523-119I2	12.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	23.70	4.31	1.08	2.15	1.08	0.00	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	8.59	0.61	4.29	3.68	0.00	0.00	0.00	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	131.19	13.05	25.45	22.84	7.18	2.61	4.57	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	39.85	5.77	11.19	10.14	2.80	0.35	0.00	0.00	0.17
Iris Pigment Epithelial Cells, donor1	11530-119I9	35.54	7.96	15.37	8.78	2.61	1.65	0.55	0.14	0.69
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	25.47	6.37	6.37	9.55	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	13.35	13.35	0.00	6.68	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	81.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	34.61	0.00	6.92	8.31	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	20.02	0.00	5.01	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	11.87	0.00	11.87	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	43.57	0.00	5.13	7.69	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	9.14	0.00	0.00	4.57	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	17.87	0.00	4.87	6.50	0.00	1.62	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	20.01	0.00	16.67	5.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	10.89	0.00	7.26	0.00	3.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	23.82	2.65	1.32	5.29	1.32	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	22.17	1.11	4.43	4.43	1.11	1.11	1.11	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	10.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	37.79	0.63	5.04	2.52	1.26	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	18.56	1.55	1.55	6.19	0.00	0.00	0.00	1.55	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	43.90	0.00	14.63	14.63	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	24.55	2.58	3.88	5.17	0.00	0.00	0.65	0.00	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	19.32	1.61	1.61	4.83	0.00	0.00	0.00	1.61	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	0.00	35.84	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	31.78	4.07	11.41	6.52	0.81	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	13.43	0.84	4.20	1.26	0.00	0.00	0.42	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	28.74	14.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	28.13	1.61	12.06	3.21	0.80	0.00	1.61	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	23.08	0.92	7.39	6.46	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	45.24	0.00	30.16	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	38.24	4.25	8.02	7.08	1.89	0.47	0.47	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	19.95	2.72	6.35	6.35	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	58.97	14.74	0.00	14.74	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	35.51	5.38	10.76	3.23	0.00	0.00	1.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	26.68	1.27	6.35	13.98	1.27	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	49.29	0.00	0.00	16.43	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	29.33	1.28	1.28	2.55	0.00	0.64	0.00	0.64	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	36.45	0.00	3.65	12.76	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	47.41	15.80	15.80	15.80	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	24.99	6.43	10.00	6.43	0.00	0.71	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	26.55	0.00	0.00	6.64	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	104.24	0.00	62.55	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	29.32	2.16	8.95	6.17	0.00	0.00	0.62	0.00	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	22.83	1.76	5.27	1.76	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	9.43	6.29	6.29	12.57	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	37.55	2.78	9.04	2.09	0.70	0.70	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	44.26	2.21	19.92	4.43	2.21	0.00	0.00	2.21	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	25.94	6.48	3.24	9.73	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	41.85	0.87	6.98	5.23	0.87	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	13.50	2.25	11.25	6.75	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	13.94	0.00	10.45	3.48	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	35.20	2.13	1.07	4.27	1.07	1.07	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	22.17	0.00	8.31	6.93	1.39	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	17.10	2.85	5.70	8.55	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	32.21	0.00	1.84	4.60	1.84	0.00	0.00	0.92	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	6.05	6.05	12.10	6.05	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	12.42	6.21	12.42	6.21	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	28.55	3.17	7.40	2.11	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	24.81	4.16	3.59	2.20	0.49	0.08	0.00	0.16	0.00
Keratinocyte - epidermal, donor2	11349-117G8	15.23	1.17	1.76	2.34	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	50.55	3.41	19.78	4.45	1.04	0.00	0.19	0.09	0.00
Keratinocyte - oral, donor1	11251-116E9	34.62	7.72	16.46	5.22	1.48	0.23	0.00	0.00	0.11
Keratocytes, donor1	11527-119I6	37.82	3.78	4.81	5.85	2.41	1.38	0.00	0.00	0.00
Keratocytes, donor2	11607-120I5	30.47	4.69	1.17	1.17	1.17	0.00	1.17	0.00	0.00
Keratocytes, donor3	11688-122I5	25.89	1.78	8.10	0.99	0.79	0.00	0.00	0.00	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	70.33	4.40	21.98	39.56	2.20	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	46.39	10.79	12.94	5.39	2.16	2.16	3.24	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	32.41	18.45	19.15	6.92	4.73	0.35	0.35	0.00	0.46
Lens Epithelial Cells, donor3	11690-122I7	21.09	3.83	12.61	8.27	1.61	0.40	0.00	0.10	0.10
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	37.00	8.18	8.30	1.07	2.85	1.30	0.12	0.12	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	47.16	6.70	5.58	0.56	3.07	0.84	0.28	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	50.69	12.12	10.86	1.42	2.05	0.94	0.47	0.16	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	37.64	10.75	1.61	2.69	2.15	0.54	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	42.86	5.04	4.10	1.58	0.95	0.00	0.00	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	37.95	6.15	5.61	0.75	1.94	0.43	0.11	0.11	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	25.85	7.80	4.10	0.41	3.28	0.00	0.00	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	33.12	3.79	1.77	0.76	1.01	0.25	0.00	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	34.34	8.02	5.07	0.42	1.55	0.70	0.14	0.14	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	27.29	10.68	3.56	1.58	1.19	0.79	0.40	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	51.77	7.37	5.82	2.52	2.33	0.78	0.19	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	19.81	3.70	2.22	0.37	0.93	0.56	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	36.58	7.67	5.23	1.39	1.39	0.00	0.00	0.00	0.70
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	48.18	6.20	5.49	0.48	0.72	1.19	0.24	0.24	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	31.45	6.87	3.57	1.65	2.33	0.14	0.55	0.00	0.27
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	35.72	10.16	6.16	0.92	2.16	0.00	0.00	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	27.75	3.43	4.36	0.00	0.62	0.31	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	32.57	4.57	4.21	0.37	1.10	0.55	0.18	0.18	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	31.59	8.89	3.62	2.30	1.97	0.33	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	27.24	5.86	2.64	0.59	1.17	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	22.65	2.99	2.49	0.75	0.75	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	36.86	7.27	2.91	0.97	0.97	0.48	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	49.82	9.16	9.43	0.81	1.62	1.08	0.00	0.00	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	40.42	9.23	5.00	1.06	1.51	0.45	0.45	0.15	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	25.40	9.33	3.11	3.11	3.11	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	48.16	9.21	7.12	1.05	3.56	0.63	0.21	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	36.39	6.47	5.11	0.30	1.20	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	34.39	13.76	3.44	2.06	3.44	0.00	0.69	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	42.90	8.28	8.47	1.13	2.07	0.00	0.19	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	27.89	3.92	6.26	0.64	0.74	0.42	0.21	0.21	0.21
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	27.62	11.15	7.75	0.97	2.91	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	32.42	6.95	3.97	0.66	3.97	0.66	0.66	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	27.26	5.70	3.84	0.87	0.74	0.37	0.00	0.12	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	37.76	14.81	3.70	0.74	1.11	0.00	0.00	0.00	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	45.71	6.67	7.41	1.48	1.73	0.25	0.74	0.49	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	28.19	7.29	4.67	0.96	0.69	0.41	0.14	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	35.38	7.40	4.18	0.32	2.57	0.64	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	47.17	5.78	6.09	0.61	2.74	0.30	0.30	0.00	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	46.75	12.60	6.72	1.12	2.10	0.56	0.56	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	29.51	10.67	5.33	2.13	2.49	0.71	0.71	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	23.75	6.30	2.42	0.00	0.97	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	21.79	2.49	4.05	0.62	1.71	0.00	0.16	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	36.17	5.73	4.30	1.07	2.86	0.72	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	35.28	6.86	6.86	0.98	1.96	0.33	0.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	16.01	2.12	1.88	0.47	1.41	0.00	0.00	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	26.61	10.27	5.57	1.73	1.98	0.37	0.12	0.50	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	29.71	4.35	4.87	0.77	1.02	0.26	0.00	0.00	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	31.63	6.27	7.16	0.60	1.49	0.30	0.90	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	24.93	4.53	6.80	11.33	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	58.30	6.14	15.34	23.01	3.07	0.77	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	38.60	6.68	11.88	25.98	0.00	1.48	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	39.35	5.08	9.73	19.46	2.96	0.85	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	37.28	2.81	21.80	23.21	0.70	0.70	1.41	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	26.15	5.60	13.08	17.75	0.93	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	36.58	6.70	5.15	14.43	3.61	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	30.93	2.38	5.95	33.30	0.00	0.00	1.19	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	44.11	5.43	13.12	16.06	3.62	0.45	0.23	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	58.75	8.43	9.89	22.39	2.62	0.29	1.16	0.00	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	63.02	6.30	27.46	26.56	4.05	0.45	0.45	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	42.27	5.96	12.06	14.90	2.30	0.41	0.14	0.27	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	40.05	7.19	8.22	14.89	1.03	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	51.87	2.12	26.11	31.76	3.18	0.35	0.00	0.71	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	42.64	11.33	8.00	23.32	2.00	0.00	1.33	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	38.20	5.09	6.11	16.81	2.04	0.00	0.51	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	56.30	5.60	24.55	26.41	2.93	1.07	0.80	0.27	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	58.57	8.31	20.03	20.22	2.46	1.13	0.19	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	44.79	9.82	8.59	15.95	2.45	1.23	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	39.96	16.31	17.12	23.65	1.63	1.63	0.82	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	62.89	7.29	23.32	23.74	2.50	0.62	0.83	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	56.89	5.89	9.53	25.78	0.56	0.28	1.12	0.00	0.28
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	37.09	8.24	17.52	24.73	6.18	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	53.13	8.71	20.90	18.87	2.90	1.16	0.58	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	54.11	5.98	9.27	20.03	2.09	0.00	0.60	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	63.07	8.30	21.58	42.05	1.66	1.11	0.55	0.55	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	34.64	7.78	13.79	18.38	1.77	0.35	0.35	0.00	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	46.10	8.48	9.59	18.44	2.21	0.00	0.00	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	26.48	8.06	11.51	21.87	0.00	1.15	1.15	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	38.38	5.37	13.82	15.35	2.30	0.38	0.38	0.77	0.77
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	37.93	7.36	7.36	13.02	0.57	1.13	0.57	0.57	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	41.84	4.10	21.33	27.08	3.28	0.82	1.64	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	24.85	8.13	14.46	20.33	1.81	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	38.06	5.75	3.59	15.08	1.44	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	49.30	7.47	29.13	35.85	2.99	1.49	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	34.56	6.69	11.15	17.09	4.83	0.37	1.49	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	39.20	4.74	9.91	13.78	6.03	0.43	0.43	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	48.81	3.43	20.55	20.55	3.43	0.86	0.00	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	36.98	5.00	12.33	20.32	3.00	0.33	1.67	0.33	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	40.42	7.84	3.62	12.07	3.02	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	29.86	5.69	16.35	17.77	2.84	0.71	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	37.81	3.78	19.94	17.53	1.72	0.00	0.69	0.00	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	34.89	6.44	5.37	15.03	1.07	0.54	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	35.01	2.69	24.24	22.22	4.04	0.00	0.00	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	38.15	5.56	14.82	11.48	2.96	0.00	0.37	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	34.89	4.65	17.44	16.28	2.33	0.00	1.16	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	32.79	9.52	20.10	19.04	1.06	0.00	2.12	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	42.42	3.20	11.60	11.20	2.00	0.00	0.00	0.40	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	23.99	5.09	4.36	12.36	0.73	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	42.16	4.60	23.76	15.33	0.00	2.30	0.77	0.77	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	28.12	6.91	11.35	9.87	4.44	0.49	0.99	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	20.70	9.41	12.23	6.59	2.82	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	44.75	6.54	22.63	20.62	0.00	1.01	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	34.25	5.86	14.42	15.32	1.80	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	22.37	1.72	3.44	5.16	1.72	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	34.74	7.57	16.48	17.81	3.56	0.00	0.00	0.00	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	35.97	6.26	6.65	22.29	0.78	0.39	0.00	0.78	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	30.35	5.28	5.94	17.81	1.98	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	24.39	8.30	20.76	21.28	1.56	0.00	1.04	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	49.45	7.00	9.63	18.82	0.88	0.00	0.88	0.44	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	35.78	6.15	3.91	19.57	2.80	0.56	0.56	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	35.33	4.42	13.69	15.46	3.97	0.44	0.44	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	37.03	8.10	14.66	15.04	1.16	0.00	0.00	0.00	0.77
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	35.95	9.62	5.06	16.71	1.52	0.51	0.00	0.00	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	33.16	2.88	21.63	18.26	1.92	0.48	0.00	0.00	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	35.78	7.55	3.98	13.52	1.99	0.80	0.80	0.00	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	34.63	7.29	6.68	11.54	3.04	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	31.13	9.68	2.08	13.83	4.15	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	38.38	6.84	23.18	18.24	3.04	0.00	0.38	0.00	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	25.30	7.23	3.10	12.39	3.10	0.52	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	46.56	6.65	2.42	19.95	2.42	0.00	0.00	0.60	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	43.42	5.70	15.53	14.58	2.22	0.00	0.95	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	34.65	8.00	6.40	10.13	0.53	0.00	1.07	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	27.01	6.32	4.60	16.09	1.72	0.00	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	30.34	7.20	11.83	12.86	3.09	0.00	1.54	1.03	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	33.95	8.49	5.66	11.32	1.41	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	19.86	7.38	2.27	17.02	2.84	0.00	0.57	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	32.03	8.32	9.57	16.22	3.33	0.42	2.08	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	37.59	8.61	4.70	18.79	3.13	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	32.15	8.77	4.18	15.03	1.25	0.00	0.42	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	28.34	8.83	13.01	18.12	2.32	0.46	1.86	0.46	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	36.80	6.02	8.03	11.37	2.68	0.00	2.01	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	29.41	8.02	2.67	11.76	1.60	0.00	1.07	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	37.58	4.85	10.51	13.34	1.62	0.40	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	35.79	6.42	1.84	15.60	2.75	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	32.90	6.22	1.78	12.45	1.78	0.00	0.89	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	34.19	4.56	21.66	24.50	2.28	0.00	0.00	0.57	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	32.98	3.83	6.90	11.50	0.00	0.00	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	50.89	4.38	4.92	17.51	1.64	0.55	2.19	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	40.09	6.68	14.25	10.25	1.78	0.45	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	41.33	5.72	11.18	13.52	1.82	0.00	1.04	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	43.77	10.61	5.30	16.58	3.98	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	18.71	4.16	12.47	16.63	4.16	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	34.19	4.79	7.07	1.82	2.05	0.23	0.23	0.46	0.23
Macrophage - monocyte derived, donor2	11313-117C8	13.40	1.65	5.51	2.02	0.18	0.37	0.37	0.73	0.00
Macrophage - monocyte derived, donor3	11389-118C3	29.76	3.41	10.75	2.49	1.84	0.79	0.79	0.52	0.26
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	38.76	18.59	6.37	4.25	3.72	0.53	1.06	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	31.85	19.81	6.34	6.65	4.44	0.32	0.16	0.00	0.16
Mallassez-derived cells, donor3	11930-125I4	42.95	14.59	6.53	6.39	2.50	0.83	0.14	0.00	0.00
Mammary Epithelial Cell, donor1	11273-116H4	26.41	4.19	9.86	6.78	1.20	0.10	0.20	0.10	0.00
Mammary Epithelial Cell, donor2	11350-117G9	28.67	9.27	7.53	7.82	1.16	0.58	0.00	0.00	0.00
Mammary Epithelial Cell, donor3	11422-118F9	21.45	2.49	7.98	2.99	0.00	0.25	0.00	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	69.15	16.95	23.05	14.91	12.20	2.71	2.03	0.00	0.68
Mast cell, donor1	11563-120D6	48.34	5.41	19.47	8.98	1.51	0.76	0.87	0.76	0.22
Mast cell, donor2	11565-120D8	44.28	7.13	18.13	5.94	1.49	0.30	0.59	1.78	0.30
Mast cell, donor3	11566-120D9	53.58	11.03	19.14	4.05	3.83	1.35	1.13	2.48	0.90
Mast cell, donor4	11567-120E1	49.46	6.21	15.07	4.43	2.48	0.71	0.71	1.95	0.35
Mast cell, expanded and stimulated, donor5	11940-126A5	30.50	2.44	15.19	5.54	0.89	0.78	0.00	0.55	0.11
Mast cell, expanded and stimulated, donor8	11942-126A7	13.42	2.92	1.75	5.84	2.92	0.00	1.17	0.58	0.00
Mast cell, expanded, donor5	11939-126A4	50.13	6.42	12.62	2.64	2.52	0.34	0.57	1.49	0.34
Mast cell, expanded, donor8	11941-126A6	37.66	4.85	6.69	3.01	1.34	0.33	0.33	1.00	0.17
Melanocyte - dark, donor1	11502-119F8	77.31	18.81	18.81	2.89	6.47	1.09	0.40	0.20	0.80
Melanocyte - dark, donor2	11582-120F7	29.42	6.58	5.54	6.58	1.04	0.35	0.35	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	21.01	12.03	10.58	2.39	6.81	2.03	1.52	0.43	0.43
Melanocyte - light, donor1	11274-116H5	6.11	1.65	0.71	1.41	0.94	0.24	0.24	0.00	0.24
Melanocyte - light, donor2	11351-117H1	4.78	2.05	1.36	0.00	0.00	0.00	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	8.67	0.87	6.94	1.73	0.87	0.00	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	29.68	12.70	5.62	1.04	2.29	1.25	1.25	0.52	0.31
Melanocyte, donor2 (MC+2)	12739-135I3	22.05	6.19	3.23	3.50	1.88	0.27	0.81	0.27	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	24.11	8.04	2.95	2.41	2.68	0.27	0.00	0.27	0.54
Meningeal Cells, donor1	11493-119E8	35.23	11.91	2.36	5.33	4.96	0.74	1.24	0.25	0.12
Meningeal Cells, donor2	11573-120E7	32.13	7.48	5.28	10.56	3.08	1.32	0.44	0.44	0.44
Meningeal Cells, donor3	11654-122E7	47.35	14.43	7.99	8.64	6.52	2.04	1.47	0.16	1.30
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	51.61	15.11	18.82	11.41	5.99	2.57	2.57	0.00	1.14
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	23.65	8.25	3.92	2.31	1.61	0.30	0.40	0.10	0.30
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	2.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	9.16	1.31	1.31	2.62	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	21.53	1.44	11.48	1.44	0.72	1.44	0.72	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	22.24	3.81	5.93	3.39	1.27	0.85	0.42	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	27.14	3.52	4.02	3.02	1.51	0.00	0.50	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	21.32	5.71	4.18	4.61	5.93	0.44	0.66	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	28.49	9.50	8.04	5.84	3.65	4.38	0.73	0.00	1.46
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	24.14	7.37	3.68	6.14	2.25	1.02	0.82	0.00	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	21.47	9.14	1.39	1.80	1.94	0.28	0.14	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	5.95	0.74	1.49	2.23	0.74	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	25.92	6.05	6.18	2.63	1.05	0.26	0.26	0.00	0.53
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	12.17	3.86	2.08	1.19	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	4.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	35.86	5.76	5.12	6.40	1.28	1.28	0.64	0.64	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	40.41	4.96	8.86	3.54	2.48	0.00	0.35	0.35	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	29.40	5.94	8.44	3.44	2.50	0.63	0.00	0.00	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	46.44	7.26	18.14	10.16	6.53	1.45	0.73	1.45	0.73
Mesothelial Cells, donor1	11247-116E5	31.03	10.87	3.71	1.59	2.39	0.80	0.80	0.27	0.27
Mesothelial Cells, donor2	12156-128G5	23.52	11.51	7.01	5.51	5.51	1.00	0.50	0.00	0.50
Mesothelial Cells, donor3	11402-118D7	33.82	4.55	9.11	3.61	1.59	1.01	0.87	0.07	0.51
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	52.66	0.00	8.10	4.05	0.00	1.35	1.35	2.70	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	28.57	2.46	4.68	4.19	1.97	0.99	0.49	0.49	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	18.26	5.30	3.24	0.88	1.77	0.29	0.59	0.29	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	65.68	0.00	3.46	3.46	0.00	3.46	0.00	3.46	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	16.74	3.10	5.58	3.10	1.24	0.00	0.62	0.31	0.62
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	18.05	2.07	4.77	1.24	0.41	0.21	0.41	1.04	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	44.00	0.00	9.26	2.32	2.32	0.00	0.00	2.32	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	16.52	3.75	3.75	2.25	1.25	0.50	0.25	0.75	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	25.14	4.19	5.12	1.40	0.93	0.47	0.47	0.00	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	14.23	3.05	4.06	2.24	1.42	0.00	0.41	0.20	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	14.25	2.38	3.96	0.40	0.79	0.40	0.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	25.65	0.00	8.55	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	14.16	1.77	2.65	1.77	0.00	0.88	0.00	2.65	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	12.16	1.90	3.80	0.76	0.00	0.00	0.00	1.14	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	34.21	1.32	6.58	3.95	1.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	12.31	1.91	3.40	1.27	0.21	0.00	0.00	0.21	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	12.89	0.92	2.76	1.84	0.00	0.92	0.92	0.92	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	14.60	1.79	1.49	2.09	0.30	0.60	0.60	0.00	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	28.50	11.74	1.68	0.00	1.68	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	15.31	1.76	1.76	1.00	0.25	0.25	0.00	0.50	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	14.97	2.61	4.28	0.95	0.24	0.00	0.24	0.71	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	24.33	6.63	5.53	1.66	1.11	0.00	0.55	0.00	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	8.98	1.84	4.14	0.69	0.23	0.23	0.23	0.23	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	11.57	2.31	4.84	0.63	0.63	0.42	0.00	0.21	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	14.68	1.83	5.10	0.82	0.20	0.00	0.61	0.61	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	11.37	2.15	2.57	1.72	0.43	0.43	0.21	0.64	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	13.78	1.78	3.33	0.44	0.89	0.67	0.22	0.44	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	20.64	0.00	0.00	10.32	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	7.67	0.66	2.41	1.75	0.44	0.44	0.44	0.66	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	14.70	0.51	3.04	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	21.54	0.00	6.63	0.00	3.31	0.00	0.00	1.66	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	10.60	0.27	3.81	2.45	0.00	0.54	0.27	0.82	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	9.12	1.47	2.06	0.88	0.59	0.00	0.00	0.88	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	13.08	1.09	1.09	1.09	0.00	0.00	1.09	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	8.17	0.00	1.44	0.96	0.48	0.48	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	8.81	1.60	3.60	0.80	0.80	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	9.60	1.37	2.74	1.37	0.00	1.37	0.00	1.37	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	6.01	0.00	1.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	8.15	2.04	0.00	0.00	0.00	0.00	2.04	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	3.94	0.88	0.88	1.31	0.44	0.00	0.88	0.44	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	20.97	0.00	4.41	1.10	0.00	0.00	2.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	10.89	1.28	5.12	1.28	1.28	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	5.95	1.24	0.74	1.74	0.25	0.25	0.00	0.25	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	9.74	0.00	2.09	0.70	0.70	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	17.68	0.00	6.63	2.21	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	6.84	3.08	1.71	1.03	1.37	0.34	0.34	0.00	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	11.82	1.75	3.94	2.63	0.44	0.00	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	28.05	4.97	3.55	1.07	0.00	0.00	0.36	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	10.94	3.09	3.09	1.96	0.28	0.28	0.00	0.00	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	9.14	1.25	3.74	1.66	1.25	0.00	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	16.90	2.91	4.66	1.17	1.17	1.17	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	8.14	1.81	2.11	1.21	0.60	0.00	0.60	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	5.43	2.09	2.92	2.09	0.00	0.42	0.83	0.00	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	28.88	7.22	14.44	0.00	7.22	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	9.24	2.77	0.92	3.69	0.00	0.92	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	12.52	1.71	5.12	1.71	1.14	0.00	0.00	0.00	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	23.08	4.97	5.53	2.63	0.41	0.28	0.55	0.00	0.28
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	8.55	2.59	2.07	0.78	0.26	0.52	0.26	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	17.16	2.14	4.72	1.29	1.72	0.43	0.86	0.43	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	22.87	4.45	12.07	1.91	1.27	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	12.28	2.14	2.40	2.40	0.53	0.00	0.00	0.27	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	15.86	5.09	5.99	1.50	0.60	0.60	0.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	24.30	4.52	6.22	1.55	1.27	0.14	0.00	0.42	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	11.78	2.87	0.32	1.91	1.91	0.00	0.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	27.20	2.43	8.62	3.10	1.55	0.44	0.88	0.22	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	23.89	3.41	6.83	2.65	1.52	0.00	0.38	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	12.22	2.84	3.69	1.99	1.70	0.85	0.28	0.28	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	22.37	3.44	6.64	0.74	1.97	0.25	0.25	0.25	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	27.37	9.12	9.12	1.96	0.00	0.65	0.65	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	19.70	4.12	4.12	2.06	2.35	0.00	0.59	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	25.08	4.90	9.80	2.31	2.02	0.00	0.29	0.58	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	17.31	2.47	7.42	0.82	0.82	1.24	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	17.87	2.98	3.28	2.08	0.89	0.00	0.89	0.00	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	15.07	0.00	3.77	0.00	0.00	3.77	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	16.04	0.00	3.56	5.35	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	29.90	5.91	5.26	1.64	0.33	0.33	0.33	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	11.57	1.05	3.16	2.10	0.00	0.00	0.00	1.05	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	24.51	5.34	4.55	1.58	1.38	0.20	0.40	0.40	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	27.01	0.93	2.79	3.73	0.00	1.86	0.93	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	31.17	1.50	6.38	2.63	0.38	0.00	0.75	0.38	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	16.25	2.93	2.66	1.86	0.27	0.00	0.53	0.53	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	23.75	3.85	2.15	1.24	2.49	0.45	0.23	0.23	0.34
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	19.89	0.74	5.16	2.21	0.74	0.00	0.74	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	29.68	4.03	3.66	1.83	1.10	0.37	0.37	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	26.45	1.56	1.56	3.11	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	36.88	3.74	1.60	2.14	2.67	0.00	0.53	1.60	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	15.46	0.00	0.00	3.86	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	26.26	5.05	4.04	1.01	1.01	1.01	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	18.13	1.69	4.64	1.26	1.26	0.00	0.00	0.00	1.26
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	54.48	8.17	4.09	6.81	0.00	0.00	1.36	2.72	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	29.88	3.18	5.09	6.36	0.64	0.64	0.64	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	42.11	7.29	6.48	0.81	1.62	1.62	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	34.74	1.51	9.06	6.04	0.00	0.00	1.51	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	28.55	0.00	0.00	5.71	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	35.89	6.52	9.79	0.00	6.52	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	9.50	4.75	4.75	4.75	0.00	0.00	0.00	0.00	4.75
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	62.75	25.10	0.00	12.55	25.10	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	20.68	3.88	4.74	3.66	0.86	0.22	0.65	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	29.79	3.66	6.79	4.18	2.09	0.52	0.52	0.52	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	34.04	6.67	6.01	6.01	2.67	1.33	2.00	0.00	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	63.02	1.25	15.03	3.76	1.67	0.42	1.25	0.00	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	82.90	12.55	27.19	4.37	4.18	2.28	2.47	0.57	0.38
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	154.80	28.73	22.34	14.36	6.38	9.58	3.19	0.00	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	38.08	0.68	3.40	2.04	2.04	1.36	0.68	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	91.88	31.24	20.21	14.70	9.19	1.84	5.51	3.68	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	64.45	4.19	7.95	0.42	0.00	0.84	0.00	0.00	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	59.97	7.21	12.09	3.49	1.86	1.63	0.93	0.00	0.46
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	65.39	4.05	4.86	1.08	0.54	0.54	0.81	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	42.89	9.25	3.78	3.57	2.52	1.26	0.42	0.00	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	155.89	55.67	22.27	11.13	11.13	0.00	11.13	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	24.82	1.49	2.98	0.50	1.49	0.99	0.00	1.49	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	41.95	6.77	9.20	1.62	1.62	1.35	0.27	0.00	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	38.54	4.31	9.29	1.13	0.91	0.68	0.45	0.68	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	40.34	3.59	6.53	0.82	1.14	0.82	0.33	0.00	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	28.98	5.83	3.28	2.73	1.64	0.36	0.36	0.36	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	46.68	6.37	2.65	1.59	2.12	0.53	1.06	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	25.81	0.60	1.20	0.60	0.60	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	38.40	14.11	11.81	2.30	2.30	0.98	0.33	0.00	0.98
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	36.75	4.07	8.94	0.65	1.14	0.81	0.33	0.16	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	46.74	6.00	5.47	2.47	2.65	0.71	1.06	0.00	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	49.23	4.22	5.63	0.00	0.70	0.70	0.00	0.70	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	43.21	5.52	7.36	0.92	0.92	0.46	1.38	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	67.16	3.86	7.39	3.21	0.32	0.00	0.32	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	41.04	12.42	16.55	3.45	1.72	1.03	1.72	0.00	0.69
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	156.76	22.76	35.40	2.53	0.00	5.06	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	42.11	5.57	6.68	4.68	2.23	0.67	0.67	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	45.30	1.69	2.54	2.96	0.42	0.42	0.42	0.42	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	35.84	4.03	4.03	0.95	0.95	1.42	0.95	0.00	0.47
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	73.83	3.86	12.88	3.00	0.86	0.43	0.86	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	63.19	72.22	0.00	0.00	9.03	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	38.32	2.33	4.33	2.00	0.33	0.67	0.33	0.00	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	24.80	2.71	3.16	3.61	2.71	0.90	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	35.32	0.79	4.76	1.19	1.19	0.79	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	40.86	4.64	2.79	0.00	1.86	0.00	0.93	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	47.67	4.54	15.13	5.68	2.27	1.14	0.76	0.00	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	32.91	2.61	9.12	1.30	0.98	0.33	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	32.25	1.74	3.92	1.31	0.87	0.44	0.44	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	33.92	5.43	6.33	6.78	2.71	0.45	0.90	0.45	0.90
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	28.22	3.53	7.94	0.88	0.88	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	25.26	1.99	2.66	0.66	1.33	0.66	0.66	0.66	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	42.16	2.98	5.95	3.97	2.98	0.00	0.00	0.00	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	34.45	0.38	4.59	1.53	0.00	0.38	0.77	0.38	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	30.24	4.23	10.59	1.21	1.51	0.30	0.30	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	22.54	3.32	4.86	1.77	1.55	0.22	1.11	0.22	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	32.53	0.00	8.13	2.71	0.68	0.00	1.36	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	76.64	61.31	15.33	0.00	0.00	5.11	5.11	0.00	5.11
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	48.77	1.83	9.15	1.83	1.83	0.00	0.00	0.00	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	43.75	1.89	8.18	1.26	0.31	0.63	1.89	0.31	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	33.59	1.21	5.75	1.51	0.30	1.21	0.61	0.30	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	30.06	3.16	5.54	1.58	0.00	0.00	0.79	0.79	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	40.81	7.94	12.47	10.20	1.13	3.40	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	91.04	25.29	25.29	10.12	0.00	5.06	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	27.45	3.73	6.21	3.48	1.61	0.37	0.00	0.50	0.12
Myoblast, donor2	11322-117D8	28.58	4.03	9.21	4.79	1.15	0.58	0.19	0.19	0.19
Myoblast, donor3	11398-118D3	31.11	5.04	10.59	4.04	3.03	0.67	0.50	0.67	0.17
NK T cell leukemia cell line:KHYG-1	10777-110G3	56.62	5.11	20.14	12.26	2.63	1.61	0.29	0.15	0.44
Natural Killer Cells, donor1	11230-116C6	33.52	9.23	4.92	5.54	0.31	1.23	0.31	0.62	0.00
Natural Killer Cells, donor2	11311-117C6	37.69	7.84	12.97	1.51	1.21	0.90	1.51	0.30	0.00
Natural Killer Cells, donor3	11387-118C1	34.97	6.81	9.02	3.50	2.58	1.47	0.55	0.55	0.37
Neural stem cells, donor1	11275-116H6	37.02	25.04	10.53	8.35	7.26	0.36	0.73	0.00	0.00
Neural stem cells, donor2	11352-117H2	55.84	21.18	15.41	1.93	7.70	0.00	1.93	1.93	0.00
Neurons, donor1	11494-119E9	48.93	23.90	15.93	17.07	17.07	3.41	4.55	1.14	1.14
Neurons, donor2	11574-120E8	51.08	17.61	10.79	5.28	9.47	3.96	3.08	0.22	2.42
Neurons, donor3	11655-122E8	69.06	28.78	27.13	27.13	15.62	7.40	4.93	1.64	0.82
Neutrophils, donor1	11233-116C9	17.63	1.86	7.42	2.78	0.00	0.00	0.00	0.93	0.00
Neutrophils, donor2	11314-117C9	11.60	5.80	0.00	0.00	0.00	2.90	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	12.22	0.61	3.05	1.22	0.00	0.00	0.00	0.00	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	31.23	4.87	7.72	4.16	0.59	0.12	0.47	0.00	0.24
Nucleus Pulposus Cell, donor2	11409-118E5	14.33	5.54	3.58	3.58	0.33	0.65	0.33	0.33	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	25.07	3.21	2.01	3.21	1.00	0.20	1.00	0.00	0.00
Olfactory epithelial cells, donor1	11933-125I7	31.11	4.27	7.71	4.68	0.55	0.28	0.28	0.14	0.14
Olfactory epithelial cells, donor2	11934-125I8	41.54	3.76	12.30	10.71	0.72	0.14	0.14	0.14	0.00
Olfactory epithelial cells, donor3	11935-125I9	43.81	4.99	11.80	7.83	1.25	0.34	0.34	0.00	0.11
Olfactory epithelial cells, donor4	11936-126A1	35.45	6.43	6.82	4.58	1.66	0.68	0.68	0.10	0.10
Oligodendrocyte - precursors, donor1	11496-119F2	48.75	6.02	14.44	4.21	4.81	0.60	0.00	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	14.46	1.91	2.55	1.91	0.85	0.00	0.64	0.00	0.00
Osteoblast - differentiated, donor2	11353-117H3	12.57	3.43	0.00	1.14	0.00	2.29	1.14	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	16.14	0.62	5.59	1.86	0.00	0.00	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	22.67	1.95	5.08	7.62	1.17	0.98	0.39	0.00	0.39
Osteoblast, donor2	11354-117H4	21.77	11.94	9.13	7.73	2.11	1.40	1.40	0.00	0.70
Osteoblast, donor3	11426-118G4	34.66	6.22	15.46	8.18	2.31	1.07	1.24	0.18	0.36
Pancreatic stromal cells, donor1	11249-116E7	37.99	5.14	7.92	2.70	1.43	0.76	0.08	0.34	0.08
Pericytes, donor1	11491-119E6	7.57	0.67	0.45	1.11	0.78	0.00	0.11	0.33	0.11
Pericytes, donor2	11571-120E5	15.62	1.81	0.45	1.58	1.13	0.00	0.23	0.00	0.00
Pericytes, donor3	11652-122E5	28.28	2.24	4.68	4.07	1.22	0.00	0.20	0.61	0.00
Perineurial Cells, donor1	11499-119F5	47.81	7.69	15.26	6.78	2.26	1.02	0.79	0.00	0.23
Perineurial Cells, donor2	11579-120F4	42.69	12.88	16.01	6.72	2.39	0.37	0.55	0.18	0.46
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	38.25	6.69	3.82	3.82	2.87	0.32	0.64	0.32	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	31.34	5.88	5.88	0.98	1.22	0.73	0.00	0.00	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	35.85	4.27	10.48	2.33	1.68	0.52	0.65	0.78	0.00
Placental Epithelial Cells, donor1	11278-116H9	33.00	1.67	8.13	1.43	0.24	0.00	0.48	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	21.07	4.44	3.33	3.33	2.22	1.11	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	35.73	2.36	14.33	3.53	1.18	0.39	0.39	0.00	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	12.97	2.85	2.53	0.95	0.63	0.00	0.00	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	15.76	2.06	1.13	1.50	1.13	0.00	0.00	0.19	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	10.44	3.13	3.65	0.78	0.52	0.26	0.13	0.39	0.13
Preadipocyte - breast, donor2	11328-117E5	20.71	1.58	6.53	1.35	0.68	0.45	0.23	0.23	0.45
Preadipocyte - omental, donor1	11468-119C1	22.16	4.80	1.81	4.48	2.66	0.53	0.21	0.21	0.00
Preadipocyte - omental, donor2	11329-117E6	18.33	6.11	6.55	0.87	1.31	0.00	0.00	0.44	0.00
Preadipocyte - omental, donor3	11403-118D8	29.08	9.74	11.32	5.01	3.29	1.15	0.57	0.43	1.00
Preadipocyte - perirenal, donor1	11469-119C2	12.80	4.92	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	11.98	1.84	2.46	1.54	0.00	0.31	0.31	0.31	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	35.24	8.50	17.00	7.44	2.66	0.89	0.89	0.18	0.71
Preadipocyte - subcutaneous, donor3	11428-118G6	27.42	4.94	13.79	7.32	0.51	1.53	0.51	0.17	0.34
Preadipocyte - visceral, donor1	11280-116I2	34.93	8.10	7.45	5.03	2.14	0.56	0.75	0.09	0.19
Preadipocyte - visceral, donor2	11357-117H7	41.42	7.82	5.98	4.14	0.92	0.92	0.00	0.00	0.00
Preadipocyte - visceral, donor3	11429-118G7	32.39	5.33	5.43	6.48	1.15	0.84	0.31	0.21	0.31
Prostate Epithelial Cells (polarized), donor1	11253-116F2	35.15	6.64	9.50	9.81	1.81	0.60	0.00	0.00	0.15
Prostate Epithelial Cells, donor2	11331-117E8	24.65	7.31	8.67	4.20	1.22	0.27	0.41	0.41	0.00
Prostate Epithelial Cells, donor3	11404-118D9	31.60	2.27	15.00	4.35	0.55	0.00	0.00	0.24	0.00
Prostate Stromal Cells, donor1	11254-116F3	28.36	5.81	9.57	4.78	2.96	0.68	0.80	0.11	0.00
Prostate Stromal Cells, donor2	11332-117E9	32.27	5.74	13.45	8.43	1.43	0.36	0.36	0.18	0.00
Prostate Stromal Cells, donor3	11405-118E1	33.16	7.72	13.45	2.92	2.92	0.94	0.21	0.42	0.63
Renal Cortical Epithelial Cells, donor1	11516-119H4	31.02	3.65	3.28	1.46	2.19	0.00	0.00	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	45.26	9.15	11.37	3.19	3.60	0.76	0.42	0.14	0.49
Renal Epithelial Cells, donor1	11517-119H5	25.36	1.52	5.58	2.54	1.01	0.00	0.51	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	33.43	4.27	5.69	2.13	2.13	0.00	0.71	0.00	1.42
Renal Epithelial Cells, donor3	11678-122H4	46.05	13.87	9.10	3.39	2.96	0.74	0.53	0.21	0.42
Renal Glomerular Endothelial Cells, donor1	11514-119H2	23.15	2.72	1.36	0.68	4.77	0.00	0.68	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	46.76	10.24	2.43	2.70	3.64	0.13	0.40	0.00	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	41.29	15.54	13.32	9.32	3.33	1.33	1.11	0.22	0.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	25.29	2.00	1.33	0.00	0.67	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	31.47	5.50	5.94	3.74	3.30	1.10	0.88	0.22	0.00
Renal Mesangial Cells, donor2	11598-120H5	50.79	2.51	6.90	1.25	1.25	0.00	0.00	0.00	0.63
Renal Mesangial Cells, donor3	11679-122H5	21.64	0.55	3.88	2.22	0.83	0.55	0.28	0.55	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	40.53	4.83	9.93	4.56	2.42	0.54	0.81	0.54	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	26.99	2.11	5.06	2.53	1.27	0.00	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	59.01	6.17	11.76	7.14	3.09	0.39	0.58	0.00	0.96
Retinal Pigment Epithelial Cells, donor0	11215-116A9	58.08	12.45	11.15	3.63	3.37	0.78	0.26	0.26	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	56.28	7.67	7.67	1.99	4.83	1.42	0.00	0.28	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	26.76	2.06	1.03	1.03	0.00	0.00	0.00	0.00	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	23.59	3.01	1.51	1.00	1.00	0.00	0.00	0.00	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	24.72	4.41	7.62	3.34	1.34	0.27	0.00	0.80	0.40
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	94.70	27.70	5.36	12.51	12.51	0.89	4.47	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	63.84	41.83	2.75	3.85	11.56	0.55	4.40	0.00	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	153.71	41.18	6.38	11.02	11.60	0.58	2.90	0.00	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	111.30	26.66	6.11	10.66	13.00	1.56	6.11	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	141.81	19.46	17.78	12.02	7.25	1.79	2.98	0.00	0.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	123.70	27.22	17.51	9.03	11.15	3.12	3.68	0.11	0.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	150.46	38.21	15.13	11.66	13.02	2.98	5.95	0.12	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	141.37	24.82	15.85	9.67	9.32	2.21	4.78	0.12	0.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	138.68	33.05	21.96	8.32	10.17	2.77	4.62	0.23	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	99.12	22.32	9.04	10.54	5.61	2.19	3.42	0.00	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	134.78	27.68	14.37	13.16	11.19	2.42	4.39	0.00	1.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	124.72	25.98	19.71	10.93	12.18	2.87	3.40	0.18	1.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	95.26	22.67	11.05	9.32	9.47	1.58	3.16	0.29	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	126.42	24.57	20.07	10.41	7.30	1.82	2.47	0.21	1.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	146.04	27.44	23.68	14.38	10.18	2.21	4.20	0.00	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	94.63	29.06	6.50	8.22	8.99	2.68	4.78	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	139.56	21.43	24.32	11.74	8.38	2.89	4.38	0.37	1.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	114.62	30.82	12.21	8.46	12.97	3.76	2.44	0.00	1.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	131.51	25.88	10.62	11.68	10.35	1.99	3.85	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	151.07	24.63	21.03	9.83	9.15	2.53	5.35	0.19	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	141.12	25.97	25.97	15.09	11.46	3.63	4.20	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	114.91	18.90	9.82	11.11	7.48	1.50	4.16	0.11	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	122.21	23.27	14.02	9.53	8.13	2.80	3.08	0.00	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	115.36	24.27	14.70	11.28	9.06	4.10	5.13	0.00	1.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	115.05	21.51	10.58	11.67	8.02	2.73	2.92	0.00	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	123.86	18.27	21.22	10.06	7.48	3.19	3.19	0.00	0.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	135.53	21.89	20.82	9.94	7.92	4.03	3.22	0.13	1.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	90.58	25.24	3.07	8.26	8.02	0.94	3.07	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	134.52	15.87	20.63	9.92	6.35	2.78	3.77	0.00	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	119.96	23.15	19.18	10.29	7.02	3.51	4.44	0.00	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	100.36	16.59	7.67	12.23	7.26	1.24	3.32	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	100.43	18.58	9.07	9.07	8.18	1.99	1.99	0.00	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	141.62	21.72	18.80	12.95	7.94	2.30	3.76	0.21	2.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	110.49	22.21	9.42	11.31	7.94	2.42	3.10	0.13	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	176.43	22.82	27.25	17.03	7.66	4.43	4.09	0.17	1.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	145.17	23.71	22.75	12.53	8.68	3.08	2.51	0.39	1.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	85.45	26.48	6.53	12.04	9.80	2.58	3.61	0.17	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	154.59	24.14	26.89	14.54	10.70	3.57	4.94	0.14	1.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	129.04	29.55	20.52	8.70	10.51	4.27	3.78	0.16	0.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	79.76	25.39	10.06	9.54	11.08	2.05	2.56	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	141.60	26.04	25.00	13.32	6.81	3.26	3.70	0.00	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	127.68	27.99	30.39	9.06	6.13	1.87	3.20	0.00	0.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	83.24	20.60	8.16	7.05	6.36	1.38	2.63	0.14	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	131.43	21.43	18.10	9.76	6.67	2.86	3.33	0.00	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	170.30	33.25	32.85	9.07	8.67	3.02	3.02	0.20	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	72.89	25.05	6.03	6.78	8.10	0.94	3.20	0.09	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	96.07	26.20	15.02	16.07	3.84	1.75	1.05	0.00	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	99.13	16.02	21.76	8.16	6.65	2.72	2.12	0.00	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	78.57	19.58	5.26	5.14	8.69	1.71	2.45	0.12	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	145.41	50.94	22.56	16.30	11.50	2.33	2.91	0.44	0.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	86.40	34.07	20.69	8.52	9.13	0.61	4.87	0.61	1.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	79.57	26.52	4.22	6.93	8.74	0.90	3.01	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	78.03	18.32	14.70	10.18	6.33	0.90	2.04	0.00	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	110.23	29.35	26.36	4.79	6.89	2.10	3.00	0.00	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	50.18	19.60	2.24	4.72	8.27	0.59	1.77	0.12	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	79.19	18.36	13.23	3.63	6.19	1.92	2.13	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	100.36	28.85	30.05	6.61	10.22	3.00	1.80	0.60	1.80
Schwann Cells, donor1	11498-119F4	27.27	4.14	3.76	4.70	1.88	0.38	0.75	0.00	0.00
Schwann Cells, donor2	11578-120F3	51.04	10.21	0.00	6.80	13.61	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	29.58	8.54	9.20	3.51	3.07	1.53	2.63	0.00	0.22
Sebocyte, donor1	11220-116B5	32.32	4.93	8.76	4.93	1.10	0.55	0.00	0.00	0.00
Sebocyte, donor2	11301-117B5	30.33	5.51	10.11	4.60	0.92	0.00	0.00	0.00	0.00
Sebocyte, donor3	11378-118B1	18.55	1.03	6.18	2.27	0.21	0.21	0.00	0.41	0.00
Sertoli Cells, donor1	11255-116F4	41.41	1.66	6.63	1.66	4.97	0.00	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	22.59	5.65	5.65	5.65	8.47	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	39.94	4.75	5.10	2.90	1.67	0.53	0.26	0.00	0.09
Skeletal Muscle Cells, donor2	11358-117H8	13.01	0.72	2.17	0.72	1.45	0.72	0.00	0.00	0.72
Skeletal Muscle Cells, donor3	11430-118G8	37.62	6.69	5.85	6.69	4.18	2.51	3.34	0.84	1.67
Skeletal Muscle Cells, donor4	11451-119A2	42.42	8.64	7.07	8.17	3.14	0.79	1.41	0.31	0.63
Skeletal Muscle Cells, donor5	11455-119A6	42.81	8.18	5.80	6.99	1.93	0.89	0.89	0.00	0.45
Skeletal Muscle Cells, donor6	11459-119B1	54.94	9.70	6.62	6.31	4.62	2.31	2.46	0.00	0.77
Skeletal Muscle Satellite Cells, donor1	11240-116D7	53.55	13.86	13.73	4.79	2.14	1.26	0.50	0.13	0.50
Skeletal Muscle Satellite Cells, donor2	11321-117D7	57.36	7.99	13.84	6.56	1.57	0.86	1.28	0.29	0.29
Skeletal Muscle Satellite Cells, donor3	11397-118D2	67.86	11.21	27.88	8.04	3.47	1.98	1.88	0.30	0.99
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	28.56	5.14	3.96	5.39	3.29	0.67	0.84	0.17	0.25
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	33.29	3.62	6.51	0.72	3.62	1.45	0.72	0.72	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	23.67	4.13	3.16	6.33	2.06	0.83	0.69	0.00	0.41
Skin - palm, donor1	10286-104F7	51.04	10.74	16.12	5.37	0.00	0.00	0.00	2.69	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	22.20	0.86	2.45	3.75	0.43	0.00	0.29	0.29	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	13.90	7.36	0.00	2.45	2.45	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	20.77	2.34	4.67	3.12	0.52	0.13	0.13	0.00	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	32.81	5.70	9.73	3.61	1.25	0.28	0.14	0.70	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	47.54	3.80	15.19	8.16	0.84	0.42	0.14	0.00	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	29.81	5.71	24.10	7.61	0.42	0.00	0.00	1.06	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	43.55	2.70	30.35	5.10	0.37	0.07	0.00	0.52	0.15
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	22.53	5.86	2.16	5.86	2.16	0.31	0.31	0.31	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	14.23	5.78	1.78	1.56	0.44	0.00	0.22	1.11	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	32.33	5.29	7.64	3.53	1.18	0.00	0.59	0.59	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	21.44	1.99	2.65	1.55	0.44	0.22	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	16.14	0.79	2.36	1.58	0.39	0.00	0.39	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	31.68	3.86	2.32	3.86	1.55	0.00	0.00	0.77	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	31.02	11.01	5.00	2.00	2.00	0.00	0.00	0.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	23.42	2.53	3.46	1.86	0.93	0.27	0.00	0.40	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	25.93	2.88	11.08	4.88	1.11	0.44	0.22	0.22	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	45.83	10.37	6.15	9.22	2.18	0.64	0.38	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	26.05	6.84	7.49	2.28	2.93	1.63	0.33	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	31.01	11.52	4.73	1.77	2.66	0.89	0.59	0.00	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	35.88	4.84	9.82	2.42	1.42	0.14	0.71	0.14	0.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	21.47	1.30	2.60	1.46	2.28	0.49	0.00	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	22.53	2.74	4.57	1.22	0.61	0.30	0.00	0.30	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	24.25	2.27	2.27	1.52	0.76	0.00	0.00	0.25	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	91.81	0.00	0.00	6.12	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	22.41	2.86	2.38	0.95	0.00	0.00	0.95	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	36.87	6.78	5.46	1.33	2.06	1.03	0.88	0.00	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	49.72	5.17	4.30	3.44	1.51	0.65	0.43	0.00	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	55.31	5.98	17.00	3.25	2.62	1.36	1.05	0.10	0.42
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	19.18	4.02	4.18	2.63	0.46	0.00	0.15	0.31	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	15.09	3.23	1.08	2.16	1.08	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	28.09	7.47	2.39	4.78	1.20	0.00	0.60	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	25.60	1.37	4.78	1.71	0.68	0.34	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	35.97	13.04	8.17	2.12	3.38	0.63	0.24	0.00	0.31
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	21.64	5.84	3.02	4.23	1.01	0.60	0.30	0.81	0.10
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	31.17	5.69	12.29	3.64	0.68	0.23	0.00	0.23	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	15.10	2.42	0.00	1.81	1.81	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	56.16	12.72	21.99	10.86	8.21	2.91	3.18	0.53	0.79
Smooth Muscle Cells - Prostate, donor1	11257-116F6	29.16	4.79	3.73	4.93	2.40	0.67	0.67	0.00	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	35.31	3.88	10.39	4.63	1.00	0.63	1.38	0.00	0.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	15.98	2.79	3.30	0.76	1.01	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	28.35	5.88	6.18	3.02	1.66	0.45	0.30	0.15	0.30
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	12.75	3.00	3.00	3.00	0.75	1.50	0.75	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	60.73	9.05	1.29	0.00	2.58	0.00	0.00	1.29	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	26.51	4.19	2.79	2.79	0.93	0.47	0.93	0.47	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	28.27	9.09	5.55	2.02	1.01	0.00	0.50	0.50	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	15.36	8.15	1.88	2.51	1.88	0.00	0.31	0.00	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	12.09	2.06	2.65	0.88	2.36	0.59	0.29	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	79.89	8.16	29.32	4.75	5.00	1.17	0.58	0.08	0.75
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	24.76	4.67	7.01	0.93	0.47	0.47	0.00	0.00	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	26.77	3.60	3.31	2.16	1.30	0.14	0.58	0.29	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	32.63	8.92	9.94	3.31	1.53	0.51	0.25	0.00	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	18.62	4.32	3.76	2.63	0.56	0.94	0.00	0.19	0.38
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	51.85	13.56	22.50	7.55	4.61	2.79	1.12	0.42	0.42
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	36.28	5.19	14.75	6.03	1.51	1.01	0.25	0.25	0.75
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	10.00	0.95	0.95	0.00	0.00	0.48	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	21.77	5.14	1.96	2.45	0.49	0.49	0.49	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	21.65	3.09	2.65	2.43	1.99	0.00	0.88	0.00	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	21.65	3.51	9.07	2.34	1.76	1.17	0.59	0.00	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	28.18	5.25	2.14	3.30	1.94	0.39	0.58	0.19	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	18.78	1.59	1.06	2.12	0.53	0.00	0.00	0.26	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	20.83	13.02	0.74	5.58	3.72	0.37	0.74	0.37	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	25.51	5.03	1.80	2.16	1.44	0.36	0.36	0.72	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	22.71	1.70	1.42	1.99	1.14	0.28	0.28	0.28	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	45.29	7.09	2.36	2.76	3.94	0.39	0.39	0.00	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	18.03	6.86	1.27	3.30	0.76	0.25	0.76	0.76	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	15.57	7.19	2.80	2.40	1.60	0.40	1.20	0.00	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	20.06	5.02	0.42	0.84	2.51	0.00	0.00	0.42	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	20.63	7.79	1.38	3.21	5.50	0.00	0.46	0.46	0.00
Synoviocyte, donor1	11291-117A4	16.33	2.36	2.02	2.52	0.34	0.00	0.17	0.50	0.17
Synoviocyte, donor2	11368-117I9	25.98	3.35	8.05	5.03	0.67	0.34	0.17	0.00	0.00
Synoviocyte, donor3	11440-118H9	21.22	2.23	4.47	2.68	0.89	0.67	0.45	0.45	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	34.66	6.79	5.00	5.00	2.50	0.36	0.36	1.07	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	15.86	0.00	0.00	1.98	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	18.99	4.17	2.32	3.70	1.39	1.16	0.23	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	28.46	3.73	6.38	2.08	0.50	0.22	0.14	0.07	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	21.26	2.32	6.19	0.77	0.39	0.00	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	13.74	2.29	4.58	0.57	0.00	0.00	0.00	0.57	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	24.36	3.69	5.04	2.58	1.48	0.12	0.00	0.98	0.37
Urethra, donor2	10319-105A4	44.96	7.19	1.80	1.80	3.60	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	25.50	2.39	5.58	2.39	1.33	0.27	0.00	0.00	0.27
Urothelial Cells, donor2	11600-120H7	15.62	2.40	4.41	1.60	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	17.42	1.60	3.21	2.29	0.92	0.00	0.00	0.00	0.00
Urothelial cells, donor0	11216-116B1	37.45	3.79	10.48	3.34	1.56	0.45	0.00	0.22	0.45
Whole blood (ribopure), donor090309, donation1	12179-129A1	29.36	6.23	0.89	5.34	3.56	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	17.16	4.29	0.00	4.29	1.43	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	23.27	2.05	3.42	4.79	1.37	0.00	0.68	0.00	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	26.17	5.17	3.44	4.48	0.34	0.34	0.00	1.03	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	27.31	4.65	2.91	2.91	0.58	0.00	0.00	0.58	1.16
Whole blood (ribopure), donor090612, donation1	12182-129A4	14.58	3.12	1.04	4.16	1.04	0.00	0.00	3.12	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	15.60	3.67	0.92	0.92	0.00	0.00	0.92	0.00	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	21.91	2.74	3.65	1.83	0.00	0.91	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	82.04	4.56	22.45	11.23	2.34	0.62	1.48	0.25	0.74
Wilms' tumor cell line:HFWT	10597-108E3	85.36	13.20	13.20	14.08	3.52	0.00	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	149.71	18.16	24.86	16.76	4.47	1.12	0.00	0.84	0.00
achilles tendon, donor2	10292-104G4	51.66	8.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	137.93	25.50	22.18	8.92	9.94	2.29	3.31	0.00	1.27
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	153.00	21.82	27.40	7.89	12.07	5.57	4.64	0.23	2.32
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	136.75	24.69	30.98	20.30	14.24	3.68	5.10	0.00	1.54
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	169.80	15.51	29.93	11.43	13.06	5.71	5.44	0.82	2.72
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	79.55	9.84	18.55	19.96	4.50	1.41	1.69	0.00	0.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	135.35	17.76	18.19	12.05	7.19	1.48	2.75	0.00	1.06
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	72.41	8.98	9.53	5.17	4.63	1.09	2.45	0.00	1.09
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	111.04	14.10	23.35	19.39	5.73	1.76	2.20	0.00	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	162.94	17.97	20.01	12.25	7.35	5.31	4.49	0.00	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	157.65	15.14	36.89	22.13	10.48	2.72	1.94	0.00	0.78
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	117.94	6.07	16.56	7.73	2.76	1.66	1.29	0.74	0.37
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	128.72	15.60	11.70	15.60	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	103.87	14.18	15.57	15.34	4.65	1.86	3.02	0.23	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	94.76	23.56	11.13	16.05	10.61	1.81	1.29	0.26	1.55
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	109.01	17.24	18.70	22.80	6.43	2.63	3.51	0.00	1.17
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	83.66	5.58	12.08	13.94	5.58	1.86	0.46	0.93	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	58.40	3.70	6.99	5.35	0.00	1.23	0.41	0.41	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	118.18	2.46	11.36	8.29	0.61	0.61	1.53	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	125.45	6.83	21.76	13.65	3.41	1.28	2.13	0.43	1.28
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	121.62	10.31	19.71	12.13	4.25	1.52	1.52	0.61	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	111.21	6.26	19.98	14.68	3.61	0.96	1.68	0.48	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	84.20	5.35	11.36	9.58	1.11	1.11	0.89	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	47.70	1.67	13.68	20.01	1.00	0.33	0.67	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	347.48	31.59	57.60	59.46	13.01	7.43	3.72	0.00	3.72
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	192.10	14.31	41.06	40.30	4.90	1.13	1.88	0.38	0.75
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	168.35	16.57	16.14	13.96	7.85	3.49	3.49	0.00	2.18
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	174.33	28.12	63.73	31.87	3.75	3.75	1.87	0.00	5.62
adenocarcinoma cell line:IM95m	10796-110I4	68.53	7.06	28.73	15.54	0.71	0.24	0.24	0.00	0.00
adipose tissue, adult, pool1	10010-101C1	10.86	3.10	1.71	0.78	1.40	0.16	0.16	0.62	0.16
adipose, donor1	10184-103D4	225.77	99.69	104.38	16.42	15.25	1.17	0.59	0.00	0.59
adipose, donor2	10185-103D5	81.91	22.30	37.31	10.95	4.06	1.22	0.41	0.81	0.41
adipose, donor3	10186-103D6	117.08	31.59	51.19	16.34	7.90	3.27	1.36	0.54	0.54
adipose, donor4	10187-103D7	230.56	81.47	22.54	13.00	11.27	4.33	2.60	0.00	3.47
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	171.87	17.04	31.25	12.78	4.10	2.37	0.95	0.16	0.95
adrenal gland, adult, pool1	10081-102A9	14.55	0.00	18.19	7.28	3.64	0.00	0.00	3.64	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	99.92	17.74	12.27	5.87	4.40	1.60	0.80	3.20	0.27
alveolar cell carcinoma cell line:SW 1573	10708-109H6	91.83	6.79	12.51	8.22	2.50	1.43	0.36	0.00	0.36
amniotic membrane cells, donor1	12235-129G3	61.90	1.85	19.48	9.04	0.46	0.00	0.00	1.16	0.23
amniotic membrane cells, donor2	12236-129G4	56.46	5.07	25.70	9.80	3.04	0.68	0.68	0.34	0.00
amniotic membrane cells, donor3	12237-129G5	72.77	0.29	12.96	5.60	0.29	0.00	0.00	1.18	0.00
amygdala - adult, donor10196	10167-103B5	15.42	1.19	4.74	2.37	0.00	0.00	0.00	0.00	1.19
amygdala, adult, donor10252	10151-102I7	14.60	1.62	10.14	0.41	1.01	0.41	0.41	3.65	0.00
amygdala, newborn, donor10223	10360-105E9	20.98	10.65	1.94	2.26	3.23	0.97	1.29	1.94	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	46.98	2.29	5.73	1.40	0.76	0.25	0.13	0.00	0.13
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	136.57	9.71	24.27	16.77	3.31	0.66	1.10	0.44	0.22
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	78.16	34.74	41.09	16.03	13.36	8.35	8.35	0.33	3.01
aorta, adult, pool1	10052-101G7	22.56	2.16	8.83	1.96	0.39	0.00	0.00	0.20	0.20
appendix, adult	10189-103D9	76.07	12.42	8.93	15.52	6.21	1.55	1.55	1.16	0.78
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	53.31	17.20	9.63	8.60	6.19	2.06	2.41	0.00	0.00
artery, adult	10190-103E1	6.79	1.36	0.00	1.36	1.36	0.00	0.00	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	34.04	16.37	7.68	2.75	2.61	0.29	0.14	0.00	0.14
b cell line:RPMI1788	10427-106D4	88.92	4.31	8.18	5.35	2.53	1.49	0.74	0.30	0.45
basal cell carcinoma cell line:TE 354.T	10702-109G9	11.38	3.05	5.27	3.33	2.22	0.55	0.28	0.55	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	59.74	6.95	10.82	6.35	1.89	0.69	0.40	0.50	0.40
bile duct carcinoma cell line:TFK-1	10496-107C1	31.30	0.67	5.69	2.85	0.00	0.00	0.00	0.00	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	62.63	10.07	17.90	33.55	3.36	0.56	2.80	1.12	0.56
bladder, adult, pool1	10011-101C2	20.32	5.43	5.32	1.41	1.96	0.43	0.11	0.43	0.22
blood, adult, pool1	10053-101G8	53.15	0.00	15.50	4.43	2.21	0.00	2.21	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	34.25	1.71	2.57	2.57	0.00	0.86	0.00	0.00	0.00
bone marrow, adult	10192-103E3	20.24	5.40	0.67	2.70	0.67	0.00	0.67	0.67	0.00
brain, adult, donor1	10084-102B3	15.38	2.05	2.05	1.03	0.00	0.00	0.00	2.05	0.00
brain, adult, pool1	10012-101C3	12.47	1.45	3.12	0.78	0.45	0.33	0.22	1.34	0.22
brain, fetal, pool1	10085-102B4	66.78	2.67	10.69	0.00	2.67	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	179.72	15.86	59.47	43.61	3.30	1.65	0.33	0.33	0.66
breast carcinoma cell line:MDA-MB-453	10419-106C5	76.77	10.49	17.72	18.72	2.75	0.50	0.62	0.62	0.12
breast, adult, donor1	10080-102A8	19.57	5.05	5.05	2.53	0.63	0.63	0.00	0.63	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	55.52	3.18	19.82	3.43	1.40	0.13	0.25	0.00	0.51
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	108.23	7.42	11.13	10.51	0.93	0.93	0.93	0.00	1.24
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	62.39	3.68	7.60	2.07	0.46	0.23	0.46	0.00	0.23
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	58.58	7.26	13.56	11.14	1.94	0.73	0.48	0.00	0.00
carcinoid cell line:NCI-H1770	10703-109H1	162.68	16.93	10.34	0.94	6.11	2.82	0.47	0.47	0.47
carcinoid cell line:NCI-H727	10735-110B6	58.08	12.25	17.28	9.41	1.97	0.11	0.22	0.11	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	145.14	31.69	18.70	6.34	7.29	2.54	1.27	0.00	1.58
carcinosarcoma cell line:JHUCS-1	10642-109A3	90.23	42.85	13.04	6.92	15.44	4.79	4.26	0.27	0.80
caudate nucleus - adult, donor10196	10177-103C6	28.78	6.91	2.30	2.30	0.00	0.00	0.00	5.76	0.00
caudate nucleus, adult, donor10252	10164-103B2	15.06	2.51	8.53	2.18	1.00	0.33	0.50	6.36	0.67
caudate nucleus, adult, donor10258	10379-105H1	22.16	0.00	3.06	0.76	0.00	0.76	0.76	6.88	0.00
caudate nucleus, newborn, donor10223	10354-105E3	23.07	10.25	3.66	2.93	2.93	0.00	0.37	0.73	0.00
cerebellum - adult, donor10196	10173-103C2	14.57	2.91	0.00	0.00	0.00	0.00	0.00	2.91	0.00
cerebellum, adult, donor10252	10166-103B4	9.61	5.76	5.34	1.07	0.64	0.43	1.07	3.63	0.43
cerebellum, adult, pool1	10083-102B2	15.87	2.76	5.86	2.41	0.34	0.69	0.34	3.10	0.00
cerebellum, newborn, donor10223	10357-105E6	14.11	14.95	7.47	4.15	7.47	0.83	0.83	1.66	0.00
cerebral meninges, adult	10188-103D8	17.40	2.27	4.03	1.51	1.26	0.00	0.25	1.01	0.00
cerebrospinal fluid, donor2	10294-104G6	29.97	2.92	2.19	0.73	0.73	0.73	0.00	0.73	0.00
cervical cancer cell line:D98-AH2	10552-107I3	50.76	6.04	8.77	2.30	2.59	0.14	1.01	0.29	0.14
cervical cancer cell line:ME-180	10553-107I4	29.66	3.98	10.11	6.13	1.16	0.33	0.17	0.50	0.17
cervix, adult, pool1	10013-101C4	35.59	5.46	7.03	2.31	0.73	0.31	0.21	0.31	0.21
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	42.78	8.36	8.64	5.02	4.74	1.95	1.53	0.56	0.70
chondrosarcoma cell line:SW 1353	10700-109G7	70.54	1.31	9.14	5.23	0.00	3.92	2.61	0.00	1.31
choriocarcinoma cell line:BeWo	10423-106C9	108.49	5.10	14.04	4.60	2.61	0.25	0.62	0.25	0.12
choriocarcinoma cell line:SCH	10785-110H2	51.63	3.45	10.10	2.46	0.74	0.12	0.49	0.00	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	90.60	1.19	16.60	2.13	0.71	0.47	0.47	0.47	0.24
chorionic membrane cells, donor1	12238-129G6	42.17	0.85	12.25	4.84	0.00	0.57	0.00	0.28	0.00
chorionic membrane cells, donor2	12239-129G7	42.06	6.07	11.34	4.87	2.98	1.29	0.20	0.10	0.10
chorionic membrane cells, donor3	12240-129G8	53.85	1.10	13.19	1.10	0.55	0.00	0.00	0.55	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	59.58	15.15	5.05	14.14	12.12	1.01	5.05	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	78.57	8.07	27.47	10.37	3.27	1.92	1.34	0.38	0.77
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	201.68	19.64	50.26	15.84	7.18	4.22	2.96	0.42	0.84
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	70.11	8.47	18.49	16.69	4.11	1.28	0.77	0.26	0.51
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	79.34	13.55	24.67	19.35	3.63	0.97	0.48	0.97	0.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	78.19	8.55	23.21	23.62	3.26	1.43	1.02	0.41	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	118.08	5.89	13.84	9.42	2.65	0.59	0.29	0.59	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	117.80	11.73	16.42	10.43	7.30	1.82	0.78	0.52	0.52
clear cell carcinoma cell line:JHOC-5	10638-108I8	53.03	2.97	9.37	1.14	0.46	0.69	0.00	0.00	0.46
clear cell carcinoma cell line:TEN	10636-108I6	40.08	6.07	9.89	2.95	1.04	0.00	0.17	0.00	0.00
colon carcinoma cell line:CACO-2	10513-107D9	72.12	16.66	18.85	8.79	2.38	0.73	0.92	0.00	0.00
colon carcinoma cell line:COLO-320	10420-106C6	80.96	9.88	9.12	2.66	2.66	0.76	0.38	0.38	0.38
colon, adult, donor1	10082-102B1	35.70	7.14	13.09	8.33	1.19	1.19	1.19	2.38	0.00
colon, adult, pool1	10014-101C5	28.67	7.87	5.05	2.47	1.06	0.24	0.35	0.35	0.35
colon, fetal, donor1	10070-101I7	83.43	2.47	28.43	8.65	1.85	1.24	0.00	1.24	0.00
common myeloid progenitor CMP, donor1	12130-128D6	174.17	13.75	18.33	22.92	4.58	0.00	4.58	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	75.11	25.04	25.04	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	17.42	19.55	5.10	19.97	7.22	0.42	1.27	0.00	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	20.22	26.71	2.87	16.30	8.30	0.75	1.36	0.30	0.60
cord blood derived cell line:COBL-a untreated	10449-106F8	25.10	28.34	7.05	16.08	7.33	1.13	2.54	0.14	0.42
corpus callosum, adult, pool1	10042-101F6	19.90	2.76	4.75	0.88	2.32	0.33	0.55	1.88	0.00
cruciate ligament, donor2	10295-104G7	25.12	4.86	0.81	0.00	0.81	0.00	0.00	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	48.15	2.41	11.24	4.01	0.80	0.00	1.61	0.80	0.00
diencephalon, adult	10193-103E4	12.48	2.16	2.64	1.20	0.48	0.24	0.24	1.92	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	104.47	11.94	20.21	6.43	5.05	2.53	1.61	0.23	1.15
ductal cell carcinoma cell line:KLM-1	10438-106E6	106.94	9.49	8.46	4.62	1.80	0.00	0.26	0.00	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	63.31	7.94	14.20	4.81	2.65	0.72	0.96	0.00	0.72
ductus deferens, adult	10196-103E7	33.39	4.98	7.48	7.97	0.00	0.50	0.00	0.50	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	82.09	14.40	23.04	15.84	1.44	0.00	1.44	1.44	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	50.02	6.62	4.41	5.89	1.47	0.74	0.00	0.00	0.00
dura mater, adult, donor1	10041-101F5	31.22	2.97	6.77	2.15	0.74	0.17	0.33	0.17	0.17
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	29.54	28.87	6.66	23.10	13.10	0.44	0.22	0.22	0.44
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	58.18	14.76	15.91	19.63	4.73	0.72	0.43	0.72	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	169.57	3.70	17.27	1.23	1.23	0.62	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	78.10	1.21	8.48	1.21	0.00	0.00	0.61	0.00	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	128.44	1.85	12.04	1.23	0.00	0.31	0.00	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	114.27	0.00	13.13	1.31	0.00	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	40.56	2.68	11.40	6.70	2.68	0.00	0.67	0.00	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	111.28	6.16	14.86	3.44	1.99	2.72	1.27	0.18	0.72
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	39.40	18.98	10.77	7.08	2.25	0.32	0.00	0.00	0.16
epidermoid carcinoma cell line:A431	10426-106D3	38.46	6.56	11.00	8.34	0.89	0.44	0.22	0.22	0.22
epidermoid carcinoma cell line:Ca Ski	10431-106D8	102.95	7.92	10.89	6.16	2.31	0.55	0.11	0.33	0.22
epididymis, adult	10197-103E8	36.00	3.77	7.95	5.86	1.67	0.42	0.42	0.84	0.21
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	71.67	6.56	4.79	0.89	1.42	0.71	0.53	0.18	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	64.49	0.79	9.44	5.90	0.79	0.00	0.00	0.39	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	72.34	7.60	22.93	3.54	2.49	0.52	0.52	0.52	0.26
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	68.50	10.83	25.59	3.44	2.46	0.59	0.89	0.79	0.20
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	89.74	7.39	32.38	4.48	2.69	1.46	0.78	0.11	0.56
esophagus, adult, pool1	10015-101C6	25.59	8.71	6.37	3.08	1.81	0.11	0.32	0.32	0.21
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	54.60	4.51	9.39	11.40	1.13	0.13	0.25	0.00	0.00
eye - muscle inferior rectus, donor1	10272-104E2	2.41	4.83	7.24	7.24	4.83	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	12.63	14.73	4.21	4.21	2.10	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	11.91	11.91	1.49	2.98	2.98	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	18.34	10.32	2.29	5.73	2.29	0.00	1.15	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	51.01	49.55	10.20	49.55	21.86	1.46	4.37	1.46	1.46
eye, fetal, donor1	10054-101G9	43.22	19.83	23.39	65.59	24.15	2.54	4.07	0.25	0.51
fibrosarcoma cell line:HT-1080	10758-110E2	39.24	5.64	7.82	1.67	1.28	0.77	0.51	0.51	0.77
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	98.05	4.75	11.40	3.09	2.14	0.47	1.19	0.00	0.24
frontal lobe, adult, pool1	10040-101F4	13.42	1.60	3.10	0.38	0.47	0.09	0.28	2.53	0.28
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	86.17	24.62	31.23	33.03	6.61	1.20	1.20	0.00	0.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	45.44	1.83	7.77	5.76	0.82	0.82	0.09	0.00	0.09
gall bladder, adult	10198-103E9	31.14	4.35	5.07	3.62	1.69	0.72	0.00	0.48	0.00
gamma delta positive T cells, donor1	11937-126A2	47.24	3.76	8.59	6.44	1.07	0.00	0.54	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	44.82	4.48	7.47	9.71	1.12	0.75	0.75	0.37	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	24.08	6.34	10.98	15.63	2.53	0.63	0.42	0.00	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	61.70	4.06	10.83	5.61	0.39	0.39	0.19	0.00	0.00
gastric cancer cell line:AZ521	10549-107H9	110.51	22.63	13.77	5.08	5.08	0.66	0.82	0.00	0.16
gastric cancer cell line:GSS	10560-108A2	106.17	14.64	9.15	10.98	3.66	0.00	0.92	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	25.36	9.37	6.40	4.57	2.51	0.23	0.91	0.00	0.00
giant cell carcinoma cell line:LU65	10487-107B1	64.25	4.59	6.88	1.84	2.64	0.46	0.34	0.69	0.34
giant cell carcinoma cell line:Lu99B	10433-106E1	44.09	1.82	7.00	1.82	0.14	0.00	0.14	0.00	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	61.11	2.74	15.21	23.69	1.25	0.00	0.00	0.25	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	69.03	15.83	5.28	5.07	6.65	3.38	2.74	0.74	1.06
glioblastoma cell line:A172, tech_rep2	10444-106F3	82.44	15.45	12.64	5.76	8.43	3.65	4.49	0.98	1.40
glioblastoma cell line:T98G	10485-107A8	67.22	24.28	11.70	8.17	6.95	1.99	1.55	0.22	0.99
glioma cell line:GI-1	10413-106B8	43.64	11.13	3.81	4.98	4.39	1.76	0.88	0.29	0.59
globus pallidus - adult, donor10196	10175-103C4	26.97	6.56	0.73	0.73	1.46	0.00	0.00	5.83	0.00
globus pallidus, adult, donor10252	10161-103A8	25.63	4.64	12.20	1.46	2.44	0.49	0.00	2.69	0.98
globus pallidus, adult, donor10258	10367-105F7	17.80	5.48	0.00	0.00	0.00	0.00	1.37	4.11	0.00
globus pallidus, newborn, donor10223	10364-105F4	20.25	3.73	3.20	0.53	1.60	0.00	0.53	1.60	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	173.75	19.58	14.68	17.13	9.79	2.45	7.34	0.00	7.34
granulocyte macrophage progenitor, donor2	12135-128E2	65.57	0.00	21.86	0.00	0.00	0.00	0.00	0.00	10.93
granulocyte macrophage progenitor, donor3	12139-128E6	62.72	31.36	15.68	15.68	0.00	5.23	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	41.28	7.04	8.64	3.52	1.60	1.28	0.64	0.00	0.32
hIPS +CCl2, biol_rep1	14383-156B9	63.36	61.52	0.46	7.80	11.02	1.38	0.92	0.00	0.46
hIPS +CCl2, biol_rep2	14384-156C1	34.29	56.70	0.00	10.06	8.23	0.00	0.91	0.91	0.00
hIPS +CCl2, biol_rep3	14385-156C2	44.44	48.31	1.93	9.66	10.31	0.64	1.29	1.29	0.00
hIPS, biol_rep1	14380-156B6	28.75	73.30	0.00	8.62	10.06	0.00	0.00	1.44	0.00
hIPS, biol_rep2	14381-156B7	28.81	45.27	0.00	11.66	10.29	0.00	2.06	1.37	0.00
hIPS, biol_rep3	14382-156B8	8.83	20.97	0.00	0.00	3.31	0.00	0.00	2.21	0.00
hairy cell leukemia cell line:Mo	10712-109I1	41.09	26.15	15.52	27.01	6.03	0.00	1.72	0.29	0.86
heart - mitral valve, adult	10205-103F7	23.92	6.28	4.19	2.39	2.09	0.90	0.60	0.90	0.30
heart - pulmonic valve, adult	10206-103F8	23.01	2.09	4.18	1.05	1.05	0.78	0.00	0.00	0.52
heart - tricuspid valve, adult	10207-103F9	17.49	1.67	3.33	3.33	0.00	0.00	0.00	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	52.65	6.33	19.39	6.12	1.22	0.61	0.20	0.00	0.61
heart, adult, diseased, donor1	10051-101G6	6.39	3.83	1.28	0.43	2.13	0.85	0.00	0.00	1.28
heart, adult, pool1	10016-101C7	14.26	4.37	2.76	1.61	1.61	0.00	0.46	0.00	0.23
heart, fetal, pool1	10046-101G1	26.29	5.65	5.03	2.26	3.08	0.92	0.41	0.21	0.31
hepatic mesenchymal tumor cell line:LI90	10778-110G4	30.85	11.11	12.34	16.04	5.55	1.23	0.93	0.00	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	159.35	48.76	35.68	29.73	5.95	1.19	1.19	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	69.06	9.72	34.36	6.74	2.98	0.88	0.44	0.00	0.55
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	70.76	8.98	31.31	8.01	3.03	1.46	0.85	0.00	0.49
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	70.94	11.92	33.25	8.99	2.73	1.01	0.81	0.20	0.81
hepatoma cell line:Li-7	10484-107A7	33.03	3.56	8.79	6.67	0.89	0.33	0.44	0.00	0.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	112.86	10.55	29.25	9.95	3.32	1.51	1.81	0.30	0.40
hippocampus - adult, donor10196	10169-103B7	14.19	1.89	0.00	0.00	2.84	0.00	1.89	2.84	0.00
hippocampus, adult, donor10252	10153-102I9	23.68	3.47	10.00	1.22	0.61	0.61	0.61	1.63	0.20
hippocampus, adult, donor10258	10374-105G5	2.99	3.49	0.00	1.49	0.00	0.00	0.50	2.49	0.00
hippocampus, newborn, donor10223	10363-105F3	17.27	4.58	1.76	3.17	1.41	0.35	0.00	1.06	0.70
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	166.01	164.79	19.53	14.65	23.19	3.66	3.66	1.83	1.83
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	120.17	64.21	22.78	6.09	14.92	1.57	1.57	0.59	0.59
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	136.09	77.95	10.41	7.11	13.71	0.76	2.29	0.76	0.25
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	182.69	27.07	23.12	3.38	3.38	0.00	0.56	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	151.05	35.37	40.02	2.07	3.61	0.26	0.26	0.52	0.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	151.08	31.51	12.15	4.56	4.18	0.76	0.38	0.76	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	115.03	27.44	18.39	7.59	4.67	0.58	1.46	0.29	0.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	109.65	20.47	41.15	7.32	4.52	1.08	0.86	0.65	0.86
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	113.03	29.20	14.60	7.51	2.50	0.42	1.25	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	68.20	31.97	32.91	20.84	5.45	0.24	0.71	0.00	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	82.45	28.77	42.27	16.07	5.95	1.61	0.96	0.16	0.80
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	79.45	30.97	27.61	12.12	4.71	2.02	0.00	0.67	2.02
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	105.00	72.14	21.13	8.76	12.83	3.44	1.10	1.41	1.10
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	78.61	86.47	16.70	14.25	10.81	1.47	2.95	0.49	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	127.42	162.33	10.47	8.73	20.07	1.75	0.87	2.62	1.75
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	151.58	30.74	39.90	5.35	4.20	0.19	0.38	0.38	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	105.97	27.04	25.73	4.36	5.23	0.44	0.44	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	137.93	37.48	16.99	13.49	4.50	0.50	0.50	0.50	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	78.56	29.58	36.36	5.65	8.29	0.94	0.94	0.19	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	80.94	31.38	27.74	8.18	10.00	1.36	0.45	0.91	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	77.37	36.65	21.61	9.40	6.89	0.31	0.63	0.63	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	45.56	23.35	25.48	15.84	6.37	1.63	0.98	0.16	0.82
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	44.71	20.03	23.52	19.74	4.64	1.45	2.03	0.29	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	51.12	23.91	14.95	25.71	6.58	1.49	0.60	0.30	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	167.93	122.30	34.92	17.74	19.95	3.51	1.85	0.92	2.40
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	152.34	102.99	33.95	20.54	19.97	4.85	2.85	1.14	1.71
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	262.14	175.98	28.58	33.07	26.54	4.08	3.27	1.22	2.04
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	133.09	51.40	39.08	16.55	7.75	1.06	1.41	0.35	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	148.55	42.44	45.61	16.47	5.07	0.63	0.95	0.63	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	174.31	47.51	17.55	16.64	6.66	0.30	0.61	1.21	1.21
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	100.84	39.30	36.72	27.92	5.17	2.59	1.03	0.52	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	94.98	40.51	29.89	19.92	8.63	0.66	0.66	0.66	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	94.66	36.68	14.37	20.27	7.18	1.03	1.03	0.77	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	64.17	37.07	19.94	33.23	5.88	1.02	2.30	0.51	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	71.94	43.16	26.50	34.08	10.60	1.51	3.03	0.00	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	80.65	41.34	10.75	45.70	7.73	0.34	2.02	0.67	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	157.95	113.27	30.43	18.84	20.29	1.45	2.66	0.72	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	199.21	188.51	14.71	22.73	24.51	2.67	4.90	0.89	0.89
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	207.32	128.78	23.90	27.32	24.88	2.44	0.98	1.95	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	143.03	40.04	34.84	6.42	3.06	0.61	0.61	0.61	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	566.06	367.62	91.09	35.79	29.28	6.51	3.25	3.25	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	223.72	64.20	30.78	11.91	6.62	0.66	0.99	1.99	0.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	99.06	35.57	26.82	13.68	5.47	1.64	0.55	0.00	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	143.31	41.62	21.71	18.09	6.88	0.00	0.72	0.36	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	120.64	32.74	12.10	10.32	5.34	1.07	0.71	1.07	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	34.61	36.99	5.97	15.51	10.74	1.19	1.19	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	66.90	51.33	29.52	30.47	10.29	1.90	1.22	0.41	1.08
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	77.32	41.22	17.78	30.17	10.51	1.89	0.27	0.27	0.54
immature langerhans cells, donor1	11904-125F5	47.22	19.61	7.51	3.63	4.36	0.48	2.91	0.24	0.24
immature langerhans cells, donor2	11905-125F6	42.78	3.17	3.96	14.26	1.58	1.58	1.58	0.00	0.00
insula, adult, pool1	10039-101F3	14.95	1.23	3.31	0.76	0.76	0.19	0.19	1.70	0.19
keratoacanthoma cell line:HKA-1	10791-110H8	53.97	2.93	13.98	5.85	0.00	0.33	0.00	0.00	0.00
kidney, adult, pool1	10017-101C8	26.23	2.80	9.11	2.80	0.70	0.20	0.00	0.10	0.00
kidney, fetal, pool1	10045-101F9	36.08	4.03	8.06	3.75	1.84	0.50	0.28	0.35	0.14
large cell lung carcinoma cell line:IA-LM	10509-107D5	73.85	1.14	11.08	3.98	0.28	0.00	0.28	0.00	0.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	33.18	1.66	4.01	2.49	0.28	0.14	0.14	0.00	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	60.74	6.97	8.62	6.79	2.75	0.37	0.18	0.18	0.18
left atrium, adult, donor1	10079-102A7	22.34	0.54	2.72	0.54	2.72	0.54	0.00	0.00	0.00
left ventricle, adult, donor1	10078-102A6	23.26	3.54	10.11	3.03	1.01	0.00	0.00	0.00	0.51
leiomyoblastoma cell line:G-402	10721-110A1	132.43	13.41	20.25	18.33	5.47	2.74	1.09	0.00	0.27
leiomyoma cell line:10964C	10569-108B2	11.86	1.44	3.23	1.08	1.08	1.08	0.00	0.36	0.00
leiomyoma cell line:15242A	10570-108B3	16.30	5.43	0.54	4.35	0.54	1.63	0.00	0.54	0.54
leiomyoma cell line:15425	10571-108B4	28.65	2.91	7.53	2.43	1.46	0.49	0.00	0.49	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	25.40	6.35	0.00	6.35	19.05	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	41.82	7.32	4.18	8.36	4.18	1.05	1.05	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	104.84	7.67	29.16	9.56	3.07	0.59	0.71	0.12	0.35
liposarcoma cell line:KMLS-1	10782-110G8	15.78	4.22	2.97	0.94	1.41	0.47	0.62	0.78	0.16
liposarcoma cell line:SW 872	10726-110A6	108.19	8.65	23.39	12.31	4.51	1.46	1.83	0.12	0.12
liver, adult, pool1	10018-101C9	29.01	1.13	6.97	2.11	0.16	0.16	0.16	0.00	0.00
liver, fetal, pool1	10086-102B5	29.16	2.82	8.47	4.70	0.94	0.00	0.94	0.94	0.00
locus coeruleus - adult, donor10196	10182-103D2	22.31	5.54	4.67	1.31	1.90	0.58	0.58	3.94	0.00
locus coeruleus, adult, donor10252	10165-103B3	16.98	4.43	8.86	0.74	1.66	0.37	0.37	2.21	0.18
locus coeruleus, adult, donor10258	10375-105G6	18.34	0.85	2.54	0.56	1.13	0.00	1.13	1.41	0.00
locus coeruleus, newborn, donor10223	10362-105F2	18.51	7.57	2.10	2.52	1.68	0.00	0.42	1.26	0.00
lung adenocarcinoma cell line:A549	10499-107C4	46.36	2.21	7.06	1.25	0.28	0.14	0.28	0.14	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	86.18	2.76	11.72	3.45	0.00	0.69	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	123.51	7.25	33.74	26.10	1.98	1.58	1.05	0.00	0.40
lung, adult, pool1	10019-101D1	31.66	4.96	7.80	2.24	0.83	0.12	0.24	0.35	0.24
lung, fetal, donor1	10068-101I5	51.09	11.42	1.14	5.14	2.57	0.00	0.29	0.57	0.00
lung, right lower lobe, adult, donor1	10075-102A3	52.24	3.67	19.70	6.42	1.37	1.37	0.46	0.46	0.92
lymph node, adult, donor1	10077-102A5	76.68	0.95	18.46	3.79	0.95	0.00	0.00	0.47	0.00
lymphangiectasia cell line:DS-1	10727-110A7	115.29	11.62	18.41	7.45	0.66	0.00	0.44	0.44	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	79.39	13.58	11.17	3.77	5.28	2.41	2.87	0.60	1.06
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	41.63	2.55	1.70	5.10	0.85	0.00	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	18.65	1.78	2.22	0.00	0.00	0.00	0.00	0.89	0.44
mature adipocyte, donor2	12232-129F9	15.36	1.87	2.28	0.42	2.08	0.00	0.00	1.04	0.21
mature adipocyte, donor3	12233-129G1	15.41	0.95	4.27	0.24	0.71	0.00	0.00	0.95	0.00
mature adipocyte, donor4	12234-129G2	26.06	3.16	6.84	0.53	0.53	1.05	0.26	0.53	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	111.51	12.15	16.44	11.67	5.00	1.43	1.19	0.48	0.48
medial frontal gyrus - adult, donor10196	10170-103B8	15.79	2.26	2.26	2.26	0.00	0.00	0.00	1.13	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	13.06	3.13	7.91	1.29	1.10	0.18	0.55	1.66	0.18
medial frontal gyrus, adult, donor10258	10368-105F8	9.21	1.27	0.64	1.27	0.32	0.00	0.95	2.86	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	21.75	12.37	5.12	2.56	6.82	0.85	2.99	1.28	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	19.07	3.54	3.54	1.69	1.18	1.01	0.34	4.39	0.34
medial temporal gyrus, adult, donor10252	10156-103A3	14.43	2.12	6.58	0.21	0.42	0.00	0.21	2.55	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	5.78	3.85	0.00	3.85	0.00	0.00	0.00	3.85	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	0.00	14.35	14.35	0.00	0.00	14.35	14.35	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	12.56	10.05	1.79	2.51	2.51	1.08	2.15	2.51	0.36
medulla oblongata - adult, donor10196	10174-103C3	17.52	3.89	3.89	1.30	0.65	0.00	0.00	3.24	0.00
medulla oblongata, adult, donor10252	10155-103A2	13.16	3.56	9.75	1.55	0.77	0.31	0.15	0.77	0.46
medulla oblongata, adult, pool1	10038-101F2	17.71	3.10	4.00	0.73	1.31	0.33	0.41	1.31	0.16
medulla oblongata, newborn, donor10223	10361-105F1	24.30	4.17	3.47	2.43	1.04	0.00	0.69	0.35	0.35
medulloblastoma cell line:D283 Med	10838-111E1	87.90	29.00	10.18	4.87	6.20	0.89	1.11	0.00	0.22
medulloblastoma cell line:ONS-76	10759-110E3	47.56	11.62	16.14	7.95	6.85	2.93	0.73	0.12	0.37
melanoma cell line:COLO 679	10514-107E1	30.62	6.18	6.76	6.76	1.58	0.43	0.43	0.14	0.14
melanoma cell line:G-361	10465-106H6	11.40	2.44	4.89	0.81	1.36	0.00	0.27	0.27	0.00
meningioma cell line:HKBMM	10691-109F7	27.14	1.81	6.69	1.99	0.18	0.00	0.00	0.36	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	134.82	59.04	9.69	10.57	13.22	3.52	7.05	0.00	2.64
merkel cell carcinoma cell line:MS-1	10844-111E7	85.54	44.33	19.70	7.26	11.41	3.89	4.15	0.26	1.30
mesenchymal precursor cell - adipose, donor1	11747-123G1	34.68	3.68	9.05	8.44	0.77	0.31	1.84	0.00	0.46
mesenchymal precursor cell - adipose, donor2	11748-123G2	25.09	3.27	6.00	4.54	0.73	0.36	0.55	0.55	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	15.74	3.31	0.83	1.66	0.83	0.41	0.41	0.83	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	20.79	6.74	4.50	2.25	1.40	1.12	0.56	0.00	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	22.53	4.04	5.58	3.85	0.58	1.16	0.19	0.00	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	16.66	4.16	4.16	0.69	0.69	0.69	0.00	0.00	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	23.00	4.46	3.26	1.20	0.51	0.34	0.34	0.34	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	15.53	3.80	3.34	2.42	0.92	0.23	0.35	0.00	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	41.12	9.02	7.56	4.51	2.79	0.53	0.53	0.00	0.66
mesenchymal precursor cell - cardiac, donor4	11755-123G9	35.11	11.48	6.75	2.97	3.24	0.27	0.27	0.14	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	48.65	16.64	4.98	3.70	3.56	0.57	0.85	0.00	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	22.40	3.62	1.65	0.99	0.33	0.00	0.00	0.66	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	44.56	12.32	8.72	5.40	1.11	0.69	0.55	0.28	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	31.07	3.49	6.28	5.59	0.70	0.00	0.70	0.35	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	29.40	6.33	6.12	4.49	1.02	1.02	0.41	0.41	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	21.57	4.31	4.67	1.08	1.08	1.08	0.72	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	33.52	8.90	4.24	2.79	1.55	0.31	0.62	0.31	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	23.48	5.93	1.82	0.23	2.05	0.23	0.68	0.46	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	43.63	13.01	4.62	5.87	2.94	0.42	0.84	0.42	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	34.52	7.92	7.17	4.78	1.94	0.30	0.30	0.00	0.60
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	54.27	11.82	4.81	2.80	1.84	0.44	0.53	0.09	0.09
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	21.72	5.52	1.84	1.84	2.58	0.37	0.00	0.00	0.74
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	19.46	6.58	2.29	0.86	1.72	0.00	0.29	0.00	0.57
mesenchymal stem cell line:Hu5/E18	10568-108B1	72.84	19.79	10.10	5.47	8.00	2.53	4.21	0.84	1.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	25.57	1.83	5.94	5.94	0.91	0.46	0.91	0.00	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	26.86	2.56	4.09	1.28	0.51	0.00	0.51	0.26	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	26.18	2.36	5.50	3.14	1.31	0.26	0.26	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	21.26	4.31	4.01	2.16	0.92	0.62	0.31	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	21.65	2.59	3.29	2.59	0.71	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	25.38	4.06	4.74	2.71	1.35	0.00	0.68	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	20.43	2.75	3.93	2.36	1.96	0.00	0.39	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	20.85	4.17	4.17	3.24	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	48.30	0.00	48.30	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	33.74	4.33	7.50	3.46	2.02	0.29	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	29.90	1.78	4.02	2.90	0.67	0.45	0.22	0.22	0.45
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	23.79	2.40	4.81	3.36	0.24	0.00	0.24	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	28.60	0.73	6.60	4.40	0.00	0.73	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	27.19	4.03	2.69	2.01	0.00	0.34	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	24.97	3.68	1.64	4.09	1.23	0.41	0.00	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	26.63	2.15	1.29	3.87	0.43	0.00	0.00	0.00	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	19.14	2.73	2.73	5.47	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	10.33	0.00	5.16	5.16	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	29.23	2.92	5.20	1.30	0.32	0.32	0.65	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	26.19	5.82	2.91	2.91	1.45	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	40.51	2.13	3.73	3.20	0.53	0.53	0.53	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	26.17	3.27	6.54	3.27	1.64	1.64	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	32.65	4.28	5.44	4.28	0.00	0.00	0.39	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	44.07	4.20	2.10	4.20	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	20.86	3.97	3.97	2.98	2.98	0.00	0.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	33.37	0.00	0.00	4.77	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	24.31	1.19	2.37	2.96	0.59	0.59	1.19	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	18.28	4.87	3.66	6.09	1.22	1.22	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	21.54	2.53	0.63	3.80	0.63	1.27	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	23.11	5.52	2.41	4.83	3.10	0.00	1.03	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	12.90	6.45	2.15	4.30	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	11.98	3.99	3.99	3.99	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	24.11	3.44	6.89	3.44	0.00	0.00	0.00	0.00	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	18.74	6.11	3.26	4.48	1.22	0.41	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	28.60	11.12	3.18	2.38	0.79	0.79	0.79	0.00	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	16.51	8.25	2.95	1.18	1.77	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	17.77	7.79	2.49	1.87	1.56	0.00	0.62	0.00	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	17.38	6.68	1.34	1.34	1.34	1.34	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	17.74	4.73	0.00	1.18	2.37	1.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	25.68	2.57	2.57	5.14	2.57	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	22.03	4.82	2.75	2.75	2.07	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	26.72	3.46	1.48	0.49	1.48	0.00	0.99	0.49	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	28.04	4.49	1.12	4.49	0.00	0.00	2.24	0.00	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	29.89	5.09	3.82	0.00	2.54	0.00	1.27	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	14.91	1.61	2.82	0.81	0.40	0.81	0.81	0.00	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	17.44	2.18	0.00	4.36	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	19.01	1.27	0.00	1.27	0.00	0.00	1.27	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	15.78	1.21	1.21	1.21	0.61	1.21	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	22.59	0.00	9.04	9.04	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	13.18	1.65	4.12	0.00	0.82	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	22.82	3.17	3.97	1.79	1.98	0.79	0.40	0.20	0.40
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	23.04	4.54	2.27	2.60	1.30	0.32	0.97	0.32	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	23.43	3.06	2.04	1.02	0.00	1.02	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	28.63	0.77	3.87	6.96	2.32	0.77	0.77	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	104.18	1.18	9.92	1.42	0.47	0.71	0.24	0.00	0.24
mesothelioma cell line:ACC-MESO-4	10494-107B8	78.31	18.30	10.19	4.17	5.79	1.16	0.93	0.93	0.93
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	34.19	8.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	24.04	7.30	4.93	1.95	2.47	0.62	0.41	0.31	0.31
mesothelioma cell line:Mero-25	10850-111F4	48.80	0.91	6.58	5.67	1.13	0.00	0.45	0.00	0.00
mesothelioma cell line:Mero-41	10851-111F5	69.43	5.13	7.09	5.87	0.73	0.49	0.98	0.00	0.00
mesothelioma cell line:Mero-48a	10852-111F6	64.21	8.64	10.63	12.84	1.99	0.00	0.66	0.00	0.22
mesothelioma cell line:Mero-82	10853-111F7	50.20	4.20	9.72	12.09	2.10	0.53	0.79	0.00	0.26
mesothelioma cell line:Mero-83	10854-111F8	80.17	8.68	9.36	9.19	3.23	0.68	0.85	0.17	0.17
mesothelioma cell line:Mero-84	10855-111F9	46.76	3.29	6.57	2.78	1.26	0.25	1.26	0.00	0.00
mesothelioma cell line:Mero-95	10856-111G1	39.75	8.07	8.07	3.31	2.90	0.83	0.21	0.41	0.41
mesothelioma cell line:NCI-H2052	10847-111F1	58.80	6.96	4.14	5.96	1.82	0.99	0.17	0.00	0.66
mesothelioma cell line:NCI-H226	10846-111E9	60.63	5.61	9.59	5.61	0.72	0.36	0.72	0.00	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	78.75	5.12	10.59	4.78	1.02	0.51	0.17	0.34	0.17
mesothelioma cell line:NCI-H28	10845-111E8	54.71	11.20	9.16	5.09	2.80	0.51	2.29	0.25	0.51
mesothelioma cell line:No36	10857-111G2	49.58	4.89	8.81	3.91	0.98	0.33	0.65	0.00	0.00
mesothelioma cell line:ONE58	10858-111G3	34.41	2.71	2.17	3.52	0.81	0.00	0.27	0.00	0.00
migratory langerhans cells, donor1	11901-125F2	68.52	14.78	10.75	10.56	5.18	0.19	0.96	0.77	0.58
migratory langerhans cells, donor2	11902-125F3	42.86	3.79	5.74	8.30	1.10	0.49	0.37	0.12	0.12
migratory langerhans cells, donor3	11903-125F4	56.18	5.38	6.46	8.26	1.08	0.54	0.54	0.18	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	60.07	0.98	16.98	0.98	0.98	0.00	0.00	0.00	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	51.92	2.54	16.74	2.33	0.42	0.85	0.21	0.00	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	97.44	6.91	38.93	10.37	2.07	0.23	0.00	0.23	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	36.35	6.47	15.98	16.75	2.66	0.95	0.38	0.19	0.38
myelodysplastic syndrome cell line:SKM-1	10772-110F7	126.58	10.53	18.29	6.47	3.51	0.74	1.85	0.74	0.37
myeloma cell line:PCM6	10474-106I6	46.25	2.57	6.33	2.97	0.79	0.40	0.40	0.20	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	50.73	6.59	7.10	1.52	2.03	1.52	1.01	0.00	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	9.61	0.59	2.55	0.98	0.00	0.00	0.39	0.78	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	32.76	5.91	13.71	4.01	1.11	0.00	0.00	0.33	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	35.67	3.90	10.30	2.72	0.88	0.00	0.00	0.74	0.07
nasal epithelial cells, donor2	12227-129F4	23.74	4.42	9.94	2.76	0.55	0.55	0.00	0.55	0.00
neuroblastoma cell line:CHP-134	10508-107D4	78.91	17.48	16.33	9.43	13.34	2.76	3.91	0.23	2.07
neuroblastoma cell line:NB-1	10539-107G8	93.73	28.81	16.09	9.92	12.91	4.49	3.55	0.75	2.25
neuroblastoma cell line:NBsusSR	10607-108F4	29.95	18.98	14.76	12.65	4.43	2.53	0.84	0.00	0.42
neuroblastoma cell line:NH-12	10555-107I6	60.19	26.09	18.64	5.03	10.62	3.73	3.54	0.19	0.93
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	65.47	21.82	17.55	7.83	5.93	1.90	1.42	0.00	0.47
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	35.79	11.09	22.33	10.93	3.01	0.79	1.27	0.00	1.11
neuroectodermal tumor cell line:TASK1	10774-110F9	93.79	19.52	24.35	4.43	4.03	1.61	1.81	0.00	0.81
neuroepithelioma cell line:SK-N-MC	10728-110A8	129.06	14.62	20.98	15.26	6.36	4.45	5.72	0.00	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	36.46	3.19	10.91	3.99	0.53	0.27	0.00	0.00	0.00
neutrophil PMN, donor1	12133-128D9	14.87	0.00	14.87	14.87	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	66.40	13.28	26.56	13.28	13.28	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	75.77	0.00	0.00	9.47	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	166.58	45.83	18.77	3.21	22.49	8.12	4.23	0.00	4.23
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	42.43	16.81	4.00	5.60	8.81	4.00	1.60	0.00	1.60
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	42.00	3.53	14.43	7.05	2.24	0.64	0.96	0.00	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	30.48	9.46	9.72	6.83	1.05	1.31	0.53	0.00	0.53
nucleus accumbens, adult, pool1	10037-101F1	13.69	1.69	3.66	1.22	0.94	0.37	0.84	2.06	0.28
occipital cortex - adult, donor10196	10172-103C1	8.24	4.12	4.12	6.18	0.00	0.00	2.06	8.24	0.00
occipital cortex, adult, donor10252	10163-103B1	14.22	4.03	6.98	1.07	0.81	0.81	0.27	1.88	0.27
occipital cortex, newborn, donor10223	10355-105E4	13.10	7.64	2.18	1.46	4.00	0.36	2.55	0.00	0.36
occipital lobe, adult, donor1	10076-102A4	26.76	0.79	6.30	1.57	1.05	0.26	0.00	1.31	0.00
occipital lobe, fetal, donor1	10073-102A1	159.63	12.87	54.50	10.30	9.44	8.58	7.72	2.15	0.86
occipital pole, adult, pool1	10036-101E9	7.02	1.58	1.97	0.47	0.32	0.16	0.24	1.18	0.16
olfactory region, adult	10195-103E6	11.08	2.87	3.63	1.91	0.76	0.19	0.38	2.48	0.00
optic nerve, donor1	10277-104E7	22.01	2.00	8.00	4.00	0.00	0.00	2.00	2.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	37.48	7.06	5.92	3.76	0.46	0.34	0.00	0.23	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	59.21	13.88	15.66	1.10	3.02	0.82	0.55	0.00	0.27
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	28.28	9.82	8.80	9.31	1.02	0.68	0.00	0.00	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	9.01	2.77	5.43	3.23	0.46	0.12	0.23	0.12	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	38.22	1.76	6.47	2.65	0.59	0.59	0.59	0.29	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	112.12	3.74	16.82	3.74	1.87	0.00	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	85.88	8.91	9.12	5.09	3.82	1.06	1.48	0.00	0.21
ovary, adult, pool1	10020-101D2	33.63	3.58	6.38	1.31	0.35	0.17	0.09	0.26	0.09
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	58.85	5.87	21.63	7.15	0.37	0.92	0.73	0.18	1.28
pancreas, adult, donor1	10049-101G4	37.63	1.88	22.58	5.64	0.94	0.00	0.00	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	102.87	7.27	19.01	7.27	1.96	0.84	0.84	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	53.83	4.77	9.37	7.33	1.19	0.00	0.34	0.17	0.17
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	68.72	5.96	14.74	8.94	1.82	0.66	0.33	0.00	0.83
paracentral gyrus, adult, pool1	10035-101E8	8.42	1.37	2.11	0.64	1.10	0.46	0.46	0.82	0.27
parietal cortex, adult, donor10258	10373-105G4	18.35	3.67	0.00	0.73	0.73	0.00	1.47	0.73	0.00
parietal lobe - adult, donor10196	10171-103B9	13.17	2.82	0.94	2.82	0.00	0.94	1.88	5.64	0.00
parietal lobe, adult, donor10252	10157-103A4	10.55	2.57	3.71	0.29	0.57	0.57	0.00	0.86	0.00
parietal lobe, adult, pool1	10034-101E7	10.13	2.38	2.82	0.70	0.88	0.70	0.18	1.15	0.09
parietal lobe, fetal, donor1	10072-101I9	124.14	14.55	40.73	18.43	9.70	6.79	7.76	2.91	1.94
parietal lobe, newborn, donor10223	10356-105E5	13.46	11.22	0.75	2.24	4.11	1.12	1.50	0.75	0.37
parotid gland, adult	10199-103F1	55.50	4.93	11.10	6.78	0.00	0.62	0.62	0.00	0.00
penis, adult	10200-103F2	17.19	7.52	2.15	1.61	0.00	0.54	0.00	1.61	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	50.39	4.46	5.39	2.97	1.49	0.00	0.37	0.00	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	42.40	8.89	8.16	2.19	1.46	0.73	0.15	0.15	0.15
pineal gland - adult, donor10196	10179-103C8	23.22	5.81	11.61	16.77	2.58	1.94	1.94	4.52	0.00
pineal gland, adult, donor10252	10160-103A7	36.72	6.51	18.95	16.58	1.78	2.96	0.00	1.78	0.59
pineal gland, adult, donor10258	10377-105G8	38.25	3.14	18.19	18.81	2.51	0.00	0.00	3.76	1.88
pituitary gland - adult, donor10196	10180-103C9	33.39	5.06	8.09	5.06	0.00	0.00	1.01	2.02	0.00
pituitary gland, adult, donor10252	10162-103A9	28.66	7.30	9.90	3.65	2.61	0.00	0.52	2.08	1.04
pituitary gland, adult, donor10258	10378-105G9	62.99	4.26	13.62	6.81	1.70	0.00	0.85	1.70	0.00
placenta, adult, pool1	10021-101D3	36.01	2.37	5.91	2.26	0.32	0.00	0.00	1.29	0.11
plasma cell leukemia cell line:ARH-77	10840-111E3	79.32	6.22	14.30	5.69	1.32	0.53	0.66	0.40	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	34.09	6.85	8.40	4.05	1.71	1.56	0.31	0.16	0.16
pons, adult, pool1	10033-101E6	10.24	2.58	1.72	0.69	1.20	0.26	0.60	2.24	0.17
postcentral gyrus, adult, pool1	10032-101E5	9.68	1.57	2.18	0.96	0.35	0.26	0.26	0.96	0.09
promyelocytes/myelocytes PMC, donor1	12132-128D8	110.84	4.18	18.82	20.91	4.18	2.09	2.09	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	93.64	33.05	11.02	0.00	5.51	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	70.41	11.74	0.00	11.74	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	162.85	12.53	18.94	2.48	4.37	2.48	1.31	0.29	1.17
prostate cancer cell line:PC-3	10439-106E7	184.04	10.16	33.03	9.26	3.81	0.91	1.27	0.36	0.18
prostate, adult, pool1	10022-101D4	32.38	4.44	6.89	2.09	1.09	0.36	0.09	0.63	0.09
putamen, adult, donor10196	10176-103C5	13.69	2.83	7.32	1.65	1.18	0.24	0.24	5.90	0.47
putamen, adult, donor10252	10152-102I8	17.65	3.92	9.80	0.00	0.00	0.00	0.00	3.92	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	25.13	22.95	0.00	4.37	3.28	0.00	1.09	1.09	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	7.01	1.21	1.69	2.90	0.72	0.48	0.97	5.07	0.00
putamen, newborn, donor10223	10365-105F5	9.75	11.24	1.50	0.00	4.50	0.00	1.50	0.75	0.00
rectal cancer cell line:TT1TKB	10469-106I1	83.21	5.24	24.44	7.27	3.20	0.87	0.87	0.00	0.00
rectum, fetal, donor1	10067-101I4	132.14	15.30	45.90	25.04	5.56	0.00	0.00	0.00	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	49.40	2.54	6.78	1.91	1.27	0.42	0.00	0.42	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	56.75	1.66	12.84	1.24	0.00	0.00	0.41	0.00	0.00
retina, adult, pool1	10030-101E3	28.43	8.95	9.44	19.78	8.65	0.80	0.99	0.99	0.60
retinoblastoma cell line:Y79	10475-106I7	107.04	40.53	23.12	18.19	29.36	10.13	7.53	0.78	2.08
rhabdomyosarcoma cell line:KYM-1	10787-110H4	92.21	2.83	28.52	8.98	1.60	0.74	0.37	0.25	0.12
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	76.49	14.90	21.93	12.65	5.06	1.97	0.84	0.00	1.12
sacrococcigeal teratoma cell line:HTST	10695-109G2	56.08	14.40	9.09	8.34	0.76	2.27	1.52	0.00	0.76
salivary acinar cells, donor1	11771-123I7	29.13	5.02	8.09	2.43	1.62	0.16	0.49	0.16	0.00
salivary acinar cells, donor2	11772-123I8	21.34	6.33	9.23	11.15	0.69	0.14	0.55	0.14	0.00
salivary acinar cells, donor3	11773-123I9	45.02	6.62	16.55	7.94	0.00	0.66	0.00	0.00	0.66
salivary gland, adult, pool1	10093-102C3	18.87	4.58	0.00	3.43	0.00	0.00	0.00	0.57	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	46.12	6.58	3.20	1.26	1.35	0.51	0.17	0.08	0.17
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	53.49	5.17	5.88	1.29	1.76	0.47	0.35	0.00	0.35
seminal vesicle, adult	10201-103F3	34.92	3.17	3.70	4.76	1.06	0.00	0.00	0.53	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	32.55	6.07	7.53	7.53	0.97	0.24	0.49	0.00	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	34.98	10.82	3.77	2.52	1.76	0.25	0.50	0.25	0.50
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	52.18	8.03	4.01	7.02	6.02	0.00	0.00	1.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	21.89	9.54	8.87	7.66	2.01	0.00	0.00	0.00	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	29.73	8.40	7.18	4.97	2.54	0.00	0.22	0.00	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	35.09	7.10	8.52	12.64	1.55	0.39	0.13	0.26	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	9.22	3.55	1.42	1.42	0.00	0.00	0.00	0.71	0.00
skeletal muscle, adult, pool1	10023-101D5	8.28	1.20	1.68	0.24	0.12	0.12	0.00	0.12	0.00
skeletal muscle, fetal, donor1	10066-101I3	51.26	7.04	8.04	7.04	4.02	2.01	1.01	0.00	0.00
skin, adult, donor1	10074-102A2	13.57	0.00	6.79	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	61.86	5.05	23.36	7.57	3.79	0.63	0.63	0.63	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	125.74	40.36	31.68	14.68	4.34	0.67	3.34	0.33	0.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	40.03	13.87	7.88	5.99	4.41	0.95	0.63	0.00	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	186.39	11.95	22.17	5.01	3.28	3.85	4.63	0.00	0.58
small cell lung carcinoma cell line:LK-2	10541-107H1	96.59	30.66	15.82	5.60	2.80	0.49	0.16	0.33	0.66
small cell lung carcinoma cell line:NCI-H82	10842-111E5	84.61	18.50	14.15	3.86	4.34	1.61	2.25	0.16	1.45
small cell lung carcinoma cell line:WA-hT	10562-108A4	46.85	15.91	14.60	7.63	3.27	1.53	1.31	0.65	0.22
small intestine, adult, pool1	10024-101D6	40.01	10.75	8.96	4.18	1.67	0.60	0.12	0.84	0.24
small intestine, fetal, donor1	10064-101I1	72.23	5.41	29.24	14.50	1.23	0.49	0.98	0.25	0.49
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	14.36	9.75	3.59	3.08	1.54	0.00	0.00	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	17.83	6.20	9.05	3.10	1.55	0.78	0.26	1.03	0.00
somatostatinoma cell line:QGP-1	10781-110G7	31.89	8.31	11.79	15.28	1.88	0.54	0.00	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	35.79	4.82	7.57	1.15	1.84	1.15	0.46	2.06	0.46
spinal cord, adult, donor10252	10159-103A6	21.29	5.91	11.43	0.39	1.58	0.79	0.00	1.18	0.39
spinal cord, adult, donor10258	10369-105F9	13.14	2.08	0.00	0.00	0.69	0.69	0.69	2.08	0.00
spinal cord, fetal, donor1	10056-101H2	63.42	4.88	15.86	7.93	4.27	2.44	0.00	1.83	1.22
spinal cord, newborn, donor10223	10359-105E8	25.72	5.05	3.67	2.76	2.30	0.46	0.46	1.84	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	29.57	2.39	12.99	5.08	1.05	0.00	0.15	0.45	0.15
spleen, adult, pool1	10025-101D7	51.54	5.84	7.27	0.88	0.88	0.99	0.11	0.22	0.22
spleen, fetal, pool1	10044-101F8	36.63	4.77	5.24	0.79	1.99	0.56	0.40	0.56	0.08
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	50.82	5.69	8.18	4.97	2.17	0.41	0.31	0.52	0.31
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	79.18	2.47	12.53	1.90	0.76	0.00	0.00	0.00	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	81.07	13.98	18.87	15.38	3.15	0.35	0.70	0.00	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	37.53	1.56	9.38	4.69	0.39	0.39	0.00	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	48.85	4.05	10.24	5.07	1.46	0.11	0.56	0.00	0.11
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	41.51	6.35	5.08	2.12	0.42	0.42	0.42	0.42	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	154.84	12.69	9.31	8.46	1.27	0.42	1.27	0.42	0.00
stomach, fetal, donor1	10062-101H8	114.27	13.88	38.45	13.88	1.07	1.07	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	34.18	2.28	5.13	6.84	0.00	0.57	0.00	0.00	0.00
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	54.27	0.00
substantia nigra, adult, donor10252	10158-103A5	15.37	4.57	6.23	1.04	1.45	0.21	0.21	1.04	0.21
substantia nigra, adult, donor10258	10371-105G2	5.17	2.59	0.00	1.55	1.55	0.00	0.52	3.10	0.00
substantia nigra, newborn, donor10223	10358-105E7	22.61	4.24	2.12	0.71	0.71	0.71	0.71	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	146.50	17.42	23.61	13.30	8.94	2.75	2.75	0.00	1.60
temporal lobe, adult, pool1	10031-101E4	8.82	1.36	2.03	0.51	0.68	0.08	0.51	0.68	0.25
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	113.25	16.38	32.05	9.26	7.12	7.83	2.85	1.42	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	54.94	13.63	5.27	4.40	7.03	0.00	2.20	0.88	0.00
tenocyte, donor1	11763-123H8	28.98	2.44	6.28	4.54	0.70	0.70	0.00	0.00	0.00
tenocyte, donor2	11765-123I1	18.69	4.20	4.96	3.05	0.00	0.00	0.00	0.76	0.00
tenocyte, donor3	11768-123I4	25.58	3.34	8.15	3.71	1.48	0.00	0.37	0.00	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	183.56	134.95	39.26	12.92	18.70	1.36	2.21	1.36	1.36
teratocarcinoma cell line:NCR-G1	10798-110I6	63.97	4.32	21.89	3.85	1.70	0.46	0.62	0.00	0.15
teratocarcinoma cell line:PA-1	10807-111A6	78.42	33.63	23.40	10.69	2.48	0.93	0.77	0.15	0.15
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	96.61	19.30	28.82	10.28	2.92	0.76	0.63	0.89	0.63
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	160.35	23.45	17.77	3.78	3.78	0.76	0.38	0.76	0.76
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	87.58	19.41	8.07	2.84	3.82	0.33	0.22	0.11	0.11
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	127.35	8.47	23.78	5.21	0.98	0.33	0.00	0.98	0.00
testis, adult, pool1	10026-101D8	26.09	14.07	5.58	1.72	6.98	3.01	3.22	3.44	1.18
testis, adult, pool2	10096-102C6	34.28	31.12	3.16	6.77	15.79	4.96	8.12	13.08	2.26
thalamus - adult, donor10196	10168-103B6	13.25	4.42	5.52	3.31	2.21	0.00	1.10	1.10	0.00
thalamus, adult, donor10252	10154-103A1	19.07	4.06	7.66	0.47	1.09	0.31	0.63	1.41	0.31
thalamus, adult, donor10258, tech_rep1	10370-105G1	4.62	3.08	0.00	3.08	1.54	1.54	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	12.52	0.82	1.98	0.82	0.99	0.00	0.00	1.48	0.16
thalamus, newborn, donor10223	10366-105F6	6.90	4.60	0.58	0.58	1.15	0.00	0.58	0.58	0.00
throat, adult	10209-103G2	22.22	5.24	5.49	3.00	1.50	0.25	0.50	0.50	0.50
throat, fetal, donor1	10061-101H7	77.40	6.09	26.51	15.84	2.44	0.61	0.61	0.30	1.22
thymic carcinoma cell line:Ty-82	10803-111A2	82.27	39.95	13.32	2.78	5.17	1.79	0.79	0.00	0.60
thymus, adult, pool1	10027-101D9	70.58	5.27	14.42	7.06	3.78	2.09	2.09	0.30	0.89
thymus, fetal, pool1	10043-101F7	58.71	7.90	15.69	5.71	3.74	1.56	1.14	0.00	0.31
thyroid carcinoma cell line:KHM-5M	10776-110G2	60.76	7.58	12.63	5.85	2.39	0.66	1.33	0.80	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	36.04	5.73	11.87	3.77	1.68	0.98	0.42	0.98	0.56
thyroid, adult, pool1	10028-101E1	31.17	2.99	10.36	3.45	0.47	0.28	0.28	0.09	0.28
thyroid, fetal, donor1	10060-101H6	77.25	3.43	31.64	13.45	1.05	0.53	0.53	0.79	0.79
tongue epidermis (fungiform papillae), donor1	10288-104F9	15.40	12.32	3.08	3.08	0.00	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	21.40	5.58	2.56	3.02	2.33	0.70	0.47	0.23	0.00
tongue, fetal, donor1	10059-101H5	52.41	6.70	13.79	7.49	4.73	0.00	1.97	0.79	1.18
tonsil, adult, pool1	10047-101G2	41.27	6.91	11.22	5.81	2.60	0.70	0.70	1.10	0.20
trachea, adult, pool1	10029-101E2	27.98	4.25	5.81	2.13	0.49	0.33	0.00	0.33	0.08
trachea, fetal, donor1	10058-101H4	44.24	6.54	15.39	8.08	0.77	0.38	0.38	0.38	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	40.39	2.83	14.17	1.77	0.71	1.06	0.35	0.00	0.71
transitional-cell carcinoma cell line:5637	10418-106C4	55.52	20.06	9.22	6.69	5.07	1.52	1.22	0.20	0.20
transitional-cell carcinoma cell line:JMSU1	10492-107B6	87.59	5.80	13.79	2.19	0.63	0.63	0.31	0.00	0.16
tridermal teratoma cell line:HGRT	10694-109G1	81.81	15.22	34.25	13.32	7.61	5.71	3.81	0.00	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	41.31	3.13	11.26	4.06	0.76	0.17	0.25	0.00	0.08
umbilical cord, fetal, donor1	10057-101H3	31.30	4.17	10.43	6.26	2.09	0.00	0.00	0.00	2.09
uterus, adult, pool1	10100-102D1	18.43	3.58	0.68	1.54	0.85	0.17	0.34	0.17	0.00
uterus, fetal, donor1	10055-101H1	72.69	6.14	25.08	8.70	3.07	1.54	0.00	1.02	0.00
vagina, adult	10204-103F6	10.99	3.23	0.65	0.65	1.94	0.00	0.00	0.00	0.00
vein, adult	10191-103E2	37.26	2.63	5.70	0.88	1.32	0.66	1.10	0.22	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	40.32	5.07	10.15	1.60	0.80	0.00	0.80	0.27	0.00

Property "Nearest transcripts" (as page type) with input value "ENST00000471260.1:41 ENST00000485550.5:64 ENST00000489072.5:-191 BT007337:-246 KJ891359:-246 AB590110:-246 DQ891741:-251 DQ894919:-251 ENST00000288344.14:-320 ENST00000490032.5:322 ENST00000652622.1:-340 ENST00000479586.5:-344 BC071643:-348 ENST00000482733.1:-349 BC023984:-359 BC072672:-359 BC070154:-368 ENST00000419378.5:-369 BC000075:-370 ENST00000380748.5:-382 ENST00000443046.5:-383 ENST00000464078.5:-383 ENST00000463631.1:-383 AB209245:-383 BC106080:-383 BC070153:-388 J02621:-390 AK315410:-392 ENST00000491183.5:-396 ENST00000380749.10:-417 ENST00000436324.5:-417 NM_004965.7:-417 ENST00000486741.5:-428 BC107741:-452 ENST00000431390.5:-469" contains invalid characters or is incomplete and therefore can cause unexpected results during a query or annotation process.